3193 instruction ru e411

Upload: johnatan13

Post on 17-Feb-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/23/2019 3193 Instruction RU e411

    1/379

    cobas e411 analyzer"$%'%()+'%%,-/+%/

  • 7/23/2019 3193 Instruction RU e411

    2/379

  • 7/23/2019 3193 Instruction RU e411

    3/379

    cobas e 411 /1/234/+%

    5"$%'%()+'%,%274%'/+-28

    !"$%')++,./"'02.01-01

  • 7/23/2019 3193 Instruction RU e411

    4/379

    cobas e 411 /1/234/+%

    9)+%3834:-1-13;

    4)6"',

    7,$,7)/

    "$&()$*,-/-0&1/2"$&()4256-72 8212$"/(9((:9;"7"7()

    1.0 3

    , ?-;"$92,292

    A7C6(D&,(D 0490 5148 018

    !#%&')*+, 0490 5148 080

    -/1/&*+, 0490 5148 001

    23#45%6*+, 0490 5148 050

    8:!3'

  • 7/23/2019 3193 Instruction RU e411

    5/379

    cobas e 411 /1/234/+%

    H))%/"%0%/J"%

    =#&+/%3#1+, :3*!D3+B+/+4+!#)!#E:3*+4/*#!63?/%%DK=!/=#!#3:?, #3#*G/@4B

    4MEDK3/63:?4+E:=!+1/%/%+,6?B)#%%DK6?/3/!+%#!+/,, =+H/,, ?:@:,+4+

    :*!'G#MH/,6!/@:,.

    US Pat. 5,147,806; US Pat. 5,779,976; US Pat. 6,325,973; US Pat. 5,466,416; US Pat.

    5,624,637; US Pat. 5,720,922; US Pat. 5,061,445; US Pat. 5,068,088; US Pat. 5,247,243; US

    Pat. 5,296,191, +6::3?/363?'MH+/=#3/%3D?@!'%:/?38

    Q')27/)

  • 7/23/2019 3193 Instruction RU e411

    6/379

    cobas e 411 /1/234/+%

  • 7/23/2019 3193 Instruction RU e411

    7/379

    @%(-B/13-

    263:!+B+)1/%/%+, 2 7 @,-?3/271C-%,-/?33: =/$

    \:%3#*3%#B+%F:!1#&+B 3 IE):! B-93

    Z:@/!G#%+/ 5 \#* +6=:45):?#35 N3!+K-*:@ R3+*/3*+ @4B=!:E+!:*+/1*:63/, B-94

    IE):! 7 \#*)#

    h@/+6*#35+%F:!1#&+M 7 \#*?DE!#35:@+%+4+E:4//

    Z+63/1#2%3/!#*3+?%:,8:1:H+ 8 :E!#)&:??IE):!/>#%%DK B-98

    2%F:!1#&+B@4B)#*#)A+*# 9 \#*#!K?+!:?#35@#%%D/=::E!#) B-99

    9 \#*=:?3:!B35#%#4+):E!#) B-100Z:*!#H/%+B, +6=:45)'/1D/?!'*:?:@63?/ Z+63/1%D,6E!:6 B-101

    D,3)/13-)3)+-:C F/)+7A \#*'@#4+35/@+%+A%D,:3*!D3D,)#=!:6B-103\#*%#)%#A#35=:)+&++*#4+E!#3:!:?+*:%3!:4/,

    B-104 \#*'cn%#?4+?#35+:=!/@/4B35

    *:%3 :4+RocheB-106

    1 91>%:/?38,%G-4%,/)1%)+3 \#*'63#%#?4+?#35+:=!/@/4B35%/-Roche *:%3!:4+B-107

    \4#66+F+*#&+B1/!E/):=#6%:63+ A-5 \#*!/@#*3+!:?#35)%#A/%+B*:%3!:4/, B-109

    ]/!D=!/@:63:!:G%:63+ A-5 \#*)#=!:6+35QC E'3D4*+?!/G+1/:G+@#%+B

    B-110

    b3+*/3*+=:E/):=#6%:63+?6+63/1/ A-18 \#*:31/%+35)#@#%+/%#=/A#35 B-111

    \#*!#6=/A#3#35/G/@%/?%D,:3A/3

    I364/G+?#%+/Z+

    DG)2"B3'/13- F/)+7C

    I6%:?D=!:

  • 7/23/2019 3193 Instruction RU e411

    8/379

    cobas e 411 /1/234/+%

    10 91>%:/?3%11C- )3L1/271C-)%%GM-138

    T?/@/%+/ D-33

    Z=+6:*+%F:!1#&+:%%DK6+

  • 7/23/2019 3193 Instruction RU e411

    9/379

    cobas e 411 /1/234/+%

    DG4%)3)+-:C

    V%#4+)#3:!cobas e 411 Roche Diagnostics cobas e 411 R3:=:4%:635M

    #?3:1#3+A/6*#B, =!:+)?:45%:

    +11'%:4:

    1:@'4B'=!#?4/%+B, *:3:!D,*:%3!:4+!'/3#%#4+)#3:!6=:1:H5M

    =:45):?#3/456*:, =!:

    'A+3D?#B, A3:=!:E+!*+6:E!#)+6%#EG/%DN3!+K-*:@#1+ +=!:@:4G#/36B

    ?=4:35@:R4/*3!:K/1+4M1+%+6&/%3%:_#*G/, =!:

    b3:!'*:?:@63?:6:@/!G+3@/3#45%:/:=+6#%+/F'%*&+,+:EH+K*:%&/=&+,

    !#E:3D6#%#4+)#3:!:1cobas e 411, 6=/&+F+*#&++, ++%F:!1#&+M=:

    +6=:45):?#%+M*:%3!:4/,, 3/K%+*/:=/!+!:?#%+B, R*63!/%%D1=!:&/@'!#1,

    1#!*+!:?*/=!:@'*3#+=!:&/@'!#1:E64'G+?#%+B.

    U',+2%"W%)'J$)/)

    >+%"',$%2/+,.:)6)[?

    2%F:!1#&+B, *:3:!#B1:G/3?#1=:%#@:E+356B@4B!#E:3D6#%#4+)#3:!:1

    cobas e 411, =:63#?4B/36B?%/6*:45*+K=/A#3%DK+R4/*3!:%%DK='E4+*#&+BK.

    P'*:?:@63?:I=/!#3:!#6:@/!G+3+%F:!1#&+M:E/):=#6%:63+, #==#!#3%DK

    6:63#?4BMH+K6+63/1D, !#E:3/66+63/1:,, #3#*G/:=+6#%+/:E64'G+?#%+B+

    !/N/%+B?:)1:G%DK=!:E4/1. _#E4+:@/!G#%+B?%#A#4/!'*:?:@63?# +?

    %#A#4/*#G@:,

    F'%*&+,R4/*3!:%%:

  • 7/23/2019 3193 Instruction RU e411

    10/379

    cobas e 411 /1/234/+%

    L',%$2T

    0:',/)9+2$

    COBI-CD

    _#*G/?R3:1!'*:?:@63?/+1//36B\!#3*+,Z=!#?:A%+*. b3:3%/E:45N:,

    @:*'1/%3@:=:4%B/3!'*:?:@63?::=/!#3:!#+6:@/!G+3+%F:!1#&+M :3:1,

    A3:?3:A%:63+%'G%:@4B!#E:3D6#%#4+)#3:!:1, %:E/)'!:?%B@/3#4+)#&++

    P'*:?:@63?#.

    COBI-CD (Z:E!#%+/?6=:1:

    :3%:6BH+,6B*R3:,:E4#63+=!+4:G/%+B. 2%3/!#*3+?%#B=:1:H5=!/@4#

    +6=:45)',3/)#*4#@*+6:@/!G#%+/, +%@/*6+4+=:+6*@4B%#K:G@/%+B

    %#+E:4//E4+)*:,*+6*:1:,+%F:!1#&++.

  • 7/23/2019 3193 Instruction RU e411

    11/379

    cobas e 411 /1/234/+%

    91>%:/?38(284/$/4Q3$/

    \XJ9"+2"7,$,792$, Z?BG+3/656?#N+14:*#45%D1=!/@63#?+3/4/1Roche =:4MED1?:=!:6#1,

    *#6#MH+16B:E'A/%+B6+63/1/#%#4+)#cobas e 411 +4+1#3/!+#4:?@4B:E'A/%+B.

    L)+%,$%0$!2"+%0$260"'/20)6 Z?BG+3/656?#N+14:*#45%D1=!/@63#?+3/4/16/!?+6#Roche @4B=:4'A/%+B

    @#45%/,N/,+%F:!1#&++=:6/!?+6%:1'6:+^)'6,=2.:)7,$,7J a#63+@4B)#1/%D, 1#3/!+#4D,!/#

  • 7/23/2019 3193 Instruction RU e411

    12/379

    cobas e 411 /1/234/+%

    @XX'"/2,%J'E 26=:45)'M36B64/@'MH+/#EE!/?+#3'!D:

    RGG-'3/+"/ 5/)J3>%'$/

    A

    ANSI

    C

    CBT

    CCITT

    CE

    CLAS 2

    CLIA

    COBI-CD

    CSA

    DdBA

    DIL

    E

    EC

    ECL

    EMC

    EN

    F

    FIFO

    HHCFA

    I

    IEC

    IVD

    K

    KVA

    L

    LDL

    LISM

    MSDS

    N

    NCCLS

    P

    PC/CC

    Q

    QC

    -#&+:%#45%D,+%63+3'363#%@#!3+)#&++ZdV

    IE'A/%+/6=:1:H5M*:1=5M3/!#

    (ComitkConsultatif International de Tklkgraphique et Tklkphonique

    , Consultative Committee for International Telegraph and

    Telephone) ]\\__(=!/G%//%#)?#%+/\:%6'453#3+?%:

    ZE:!%+*?6=:1:

  • 7/23/2019 3193 Instruction RU e411

    13/379

    cobas e 411 /1/234/+%

    RGG-'3/+"/ D,-(-2-13-

    S

    SD Z3#%@#!3%:/:3*4:%/%+/

    S/R IE!#)/&/!/#

    *:%F+

  • 7/23/2019 3193 Instruction RU e411

    14/379

    cobas e 411 /1/234/+%

  • 7/23/2019 3193 Instruction RU e411

    15/379

    D,3)/13-)3)+-:C

    1 >+^)'6,=2.:)X"7):,0+)0%2 .......................................... A-3

    2 \X7)'020%"6E .................................................................... A-25

    3 `)

  • 7/23/2019 3193 Instruction RU e411

    16/379

  • 7/23/2019 3193 Instruction RU e411

    17/379

    Roche DiagnosticsA-3 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    91>%:/?38,%G-4%,/)1%)+3

    8/!/@%#A#4:1!#E:3D6#%#4+)#3:!:1cobas e 411, ?#G%:=!:A+3#35+=:%B35

    =!/@'=!/G@/%+B+!/*:1/%@#&++=:E/):=#6%:63+, 6:@/!G#H+/6B?R3:1

    !'*:?:@63?/.

    Z4/@'MH+/1/!D=!/@:63:!:G%:63+++%63!'*&++=!/@%#)%#A/%D@4B

    :=/!#3:!:?+@4B?6/K:3?/363?/%%DK)#'=!#?4/%+/#%#4+)#3:!:1.

    TV+%;L2/'- !"$"

    \4#66+F+*#&+BE/):=#6%:63+ ................................................................................... 5

    ]/!D=!/@:63:!:G%:63+ ......................................................................................... 5

    8!/@'=!/G@/%+B ................................................................................................. 5

    C+:4:

    P#6=:4:G/%+/R3+*/3:*=:E/):=#6%:63+%#1:@'4/#%#4+)#3:!#(@+6*:?#B6+63/1#) ....................................................................................................... 19

    P#6=:4:G/%+/R3+*/3:*=:E/):=#6%:63+%#1:@'4/#%#4+)#3:!#(N3#3+?%#B

    6+63/1#) ....................................................................................................... 20

    P#6=:4:G/%+/R3+*/3:*=:E/):=#6%:63+%#=:@@:%/@4B3?/!@DK:3K:@:?+

    )#1/%B/1:1?*4#@DN/ ................................................................................. 21

    263:A%+*=+3#%+B ............................................................................................ 22

    _'1E4/!=+3#%+B ........................................................................................ 22

    _'1E4/!D=+3#%+BN3#3+?%:

  • 7/23/2019 3193 Instruction RU e411

    18/379

    Roche DiagnosticsA-4 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

  • 7/23/2019 3193 Instruction RU e411

    19/379

    Roche DiagnosticsA-5 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    L!,002 2$,=2.X"7):,0+)0%2

    =2/))3>3$/?38G-4%,/)1%)+3

    b3#6/*&+B=:B6%B/3, *#*=!/@'=!/G@#MH#B+%F:!1#&+B'*#)D?#/36B?

    !'*:?:@63?/.

    e T@#%%:1!'*:?:@63?/, )%#*+E/):=#6%:63++6=:45)'M36B@4B=!+?4/A/%+B?#N/

  • 7/23/2019 3193 Instruction RU e411

    20/379

    Roche DiagnosticsA-6 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `"'E:'"

    K%L1"+/8323,%'-B(-11/82%,/)+7:3$%J/3$%'%L%:3$)-/

    4"0D2X,T%"62$0"'/)/'"6.)920%$2.d0!262$0"':)/'"7X"D,T%" :'.6)D) $)+%,$%, 0 '",D"+%,62 2 )92[,P[262 ',0%/)',62. H!"

    !PX)"/'"6..

  • 7/23/2019 3193 Instruction RU e411

    21/379

    Roche DiagnosticsA-7 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `"'E:'"

    W%2$"%$)T.4")%$'E/,T%"7,7):'):2!)/ET,!$)D)!?2 W%,+)! (70%)./!.P%0.D)'P9262/"["0%/,62,

    226""%0.):,0+)0%?/)7+2$+)/"+2.:)b,',, /7'E/, 2!2:)!J9"+2.)b)D)/.

  • 7/23/2019 3193 Instruction RU e411

    22/379

    Roche DiagnosticsA-8 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `"'E:'"+,9",6)DJ%XE%?:)!J9"+E+"%)9+E"

    \0J["0%/!.T%" :',/2!?+)" )X0!Jb2/,+2" 020%"6E

  • 7/23/2019 3193 Instruction RU e411

    23/379

    Roche DiagnosticsA-9 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `"'E:'"

  • 7/23/2019 3193 Instruction RU e411

    24/379

    Roche DiagnosticsA-10 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `"'E:'"3$/?38%,-/+%/

    4"/E:)!+.T%"):"',=222)X0!Jb2/,+2"020%"6E, "0!2/E+"XE!20:"=2,!?+))XJ9"+E

    ,/%)'27)/,++E6:"'0)+,!)6Roche Diagnostic.N+26,%"!?+)0!"

    :"'0)+,!,Roche..H!"

    4"$)''"$%+)276"'"++ET'"7J!?%,%6)b"%:'2/"0%2$)_2X)9+)T Q')/"'?%", 9%)276"'"+2.$)+%')!.$,9"0%/,+,Y)

    ',X)%E.

    O/:-1/-/L-1+1CY$/))-+

    >+0%'J6"+%

  • 7/23/2019 3193 Instruction RU e411

    25/379

    Roche DiagnosticsA-11 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `"'E:'"

    9),/-13-%G/4?/

    d0!2)X',7"=XE!+,X)'%J2+0%'J6"+%,X)!""0:,'"+2")X',7=)/, $)%)'E"XE!2+,X)'%JX)!""

    0X2)):,0+E626,%"'2,!,62.

    H!"

  • 7/23/2019 3193 Instruction RU e411

    26/379

    Roche DiagnosticsA-12 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `"'E:'"

    )%Y)

    /,_"T$)b"T, :'26"+2%" N0"D

    H)X!P

    d0!2$,$)T-!2X)X2)!)D29"0$2):,0+ET6,%"'2,!)$,b"%0.+,/,_"T$)b", +"6"

    K-(%)+--B-138

    R2P:313-'C-Q/)+3

    4"20:)!?7JT%"$20!)%+E"2!2,!$,!2+)/E"',0%/)'E

  • 7/23/2019 3193 Instruction RU e411

    27/379

    Roche DiagnosticsA-13 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `"'E:'"

  • 7/23/2019 3193 Instruction RU e411

    28/379

    Roche DiagnosticsA-14 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `"'E:'"

  • 7/23/2019 3193 Instruction RU e411

    29/379

    Roche DiagnosticsA-15 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `"'E:'"

    4"20:)!?7JT%")'D,+29"0$2"',0%/)'2%"!2, $')6"27):'):2!)/)D),!$)D)!.2!2

    W%,+)!,

    b%+%-)-1)%C

    fJ

  • 7/23/2019 3193 Instruction RU e411

    30/379

    Roche DiagnosticsA-16 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `"'E:'"+,9", /E6)b"%":)!J92%?%',/6J.

    Q')/"'?%", 9%)9"Y)!')%)','",D"+%)/7,$'E%/)/'"6.',X)%E, "0!2/E+"7,6"+."%"

    '",D"+%E.d0!2$'E_$,XJ

    0))X["+2".

    8,$'E/,T%"[2%)$02::"',:)0!"7,6"+E020%"6+)D)'",D"+%,2!2/E:)!+"+2.

    )X0!Jb2/,+2., 2+,9"2+0%'J6"+%+"+,9+"%',X)%J.

    K%+-Q$3

    4"6"

    '"$)6"+

  • 7/23/2019 3193 Instruction RU e411

    31/379

    Roche DiagnosticsA-17 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `"'E:'"

  • 7/23/2019 3193 Instruction RU e411

    32/379

    Roche DiagnosticsA-18 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `,'$2')/$2X"7):,0+)0%2/020%"6"

    H/$3%'$3G-4%,/)1%)+3')3)+-:-

    8!/@'=!/G@#MH+/R3+*/3*+!#)1/H/%D?6+63/1/, A3:ED=!+?4/A5?#N/?%+1#%+/*

    =:3/%&+#45%::=#6%D1:E4#63B1. b3+*/3*+++K:=+6#%+/=/!/A+64/%D%+G/, ?

    6::3?/363?++6:E4#63B1+?6+63/1/,

    b3#R3+*/3*#'*#)D?#/3, A3:+1//36B?/!:B3%:635

    ?:)%+*%:?/%+B:=#6%DK6+3'#&+,?E4+)+1/63#!#6=:4:G/%+BR3+*/3*+, *:3:!D/1:

    =!#?+4#E/):=#6%:63+.

    K-(",-B(-13-: :-Y/13Q-)$3-Q/)+3

    b3+*/3*#'*#)D?#/3, A3:?:E4#63++1//36B:=#6%:635*:%3#*3#6

    @?+G'H+1+6B1/K#%+A/6*+1+A#63B1+.

    =%%43;1C-:/+-3/2C

    b3#R3+*/3*#'*#)D?#/3, A3:?E4+)+//!#6=:4:G/%+B

    %/:EK:@+1:=:45):?#356B)#H+3%D1+:A*#1++

    =/!A#3*#1+, 3#**#*+1//36B:=#6%:635

    *:%3#*3+!:?#%+B6*:!!:)+,%D1+1#3/!+#4#1+.

    STAT %3-1+/?38J+/+3'/

    QFdc\HBdFdjd4>d:Q'2J0%,+)/$"STAT

    _%,%2/,, :')/"'?%""D)+,:',/!"+2".

    b3#R3+*/3*#6:@/!G+3=!/@'=!/G@/%+/, A3:

    N3#3+?D@:4G%D=:1/H#356B?STAT (\:!:3*:

  • 7/23/2019 3193 Instruction RU e411

    33/379

    Roche DiagnosticsA-19 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `,'$2')/$2X"7):,0+)0%2/020%"6"

    K%2%B-13-V+3$-+%$G-4%,/)1%)+31/:%("2-/1/234/+%/((3)$%'/8)3)+-:/)

    8!/@'=!/G@#MH+/R3+*/3*+=!+*!/=4BM36B%#+%63!'1/%3?64/@'MH+K=:)+&+BK:

    53). A-1 "$&')'*+-.+/1.2+1'23+4'&"$-'$1.:5'67)9"-").4"1':"(6.$2'

  • 7/23/2019 3193 Instruction RU e411

    34/379

    Roche DiagnosticsA-20 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `,'$2')/$2X"7):,0+)0%2/020%"6"

    K%2%B-13-V+3$-+%$G-4%,/)1%)+31/:%("2-/1/234/+%/(J+/+3'1/8)3)+-:/)

    8!/@'=!/G@#MH+/R3+*/3*+=!+*!/=4BM36B%#+%63!'1/%3?64/@'MH+K=:)+&+BK:

    53). A-2 "$&')'*+-.+/1.2+1'23+4'&"$-'$1.:5'67)9"-").4"1':"(>1"1.

  • 7/23/2019 3193 Instruction RU e411

    35/379

    Roche DiagnosticsA-21 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `,'$2')/$2X"7):,0+)0%2/020%"6"

    K%2%B-13-V+3$-+%$G-4%,/)1%)+31/,%((%1-(28+'-(CY%+Y%(%'3):-11%:'$2/(CJ-

    8!/@'=!/G@#MH+/R3+*/3*+=!+*!/=4BM36B**:%3/,%/!'@4B3?/!@DK:3K:@:?

    +61/%%D1?*4#@DN#1?64/@'MH+K=:)+&+BK.

    53). A-3 "$&')'*+-.+/1.2+1'23+4'&"$-'$1.: &'66'-6)=1

  • 7/23/2019 3193 Instruction RU e411

    36/379

    Roche DiagnosticsA-22 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%

    `,'$2')/$2X"7):,0+)0%2/020%"6"

    9)+%Q13$,3+/138

    H-C,%V2-$+3Q-)$%;G-4%,/)1%)+3

    4":'"

    Z4/@'MH+,!+6'%:*=:*#)D?#/33'1E4/!=+3#%+B+*#E/45=+3#%+B.

    53). A-4 "$&')'*+-.+/1.2+12.3+4'&"$-'$1.: 1753)+:'$-'

  • 7/23/2019 3193 Instruction RU e411

    37/379

    Roche DiagnosticsA-23 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3

    `,'$2')/$2X"7):,0+)0%2/020%"6"

    [":G2-,3+/138J+/+3'1%L%G2%$/,--1%)$3%G/4?%'

    Z4/@'MH+,!+6'%:*=:*#)D?#/33'1E4/!=+3#%+BN3#3+?%:

  • 7/23/2019 3193 Instruction RU e411

    38/379

    Roche DiagnosticsA-24 5"$%'%()+'%%,-/+%/ T-)381.0

    1 91>%:/?38,%G-4%,/)1%)+3 cobas e411 /1/234/+%

    `,'$2')/$2X"7):,0+)0%2/020%"6"

  • 7/23/2019 3193 Instruction RU e411

    39/379

    Roche DiagnosticsA-25 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    DG4%)3)+-:C

    b3#

  • 7/23/2019 3193 Instruction RU e411

    40/379

    Roche DiagnosticsA-26 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    ]:@'45'=!#?4/%+B ......................................................................................... 44

    ]#!*+!:?*#*:%3/,%/!#%#E:!#!/#

  • 7/23/2019 3193 Instruction RU e411

    41/379

    Roche DiagnosticsA-27 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    \X7)',+,!27,%)',cobas e 411

    DG4%/1/234/+%/cobas e 411

    211'%:4:

    Z+63/1#6:63:+3+)#%#4+)#3:!#, *:3:!D,?D=:4%B/3?6/F'%*&++%/:EK:@+1D/

    @4B=:4%:,#?3:1#3+)#&++:E!#E:3*+:E!#)&:?+#%#4+):?, +1:@'4B

    '=!#?4/%+B, *:3:!D,'=!#?4B/3#%#4+)#3:!:1A/!/)=:45):?#3/456*:/

    =!:

    :=!/@/4/%+BECL, +=/!/@#A'!/)'453#3:?.

    8!:

    !/)'453#3D, 6:)@#/3@:*'1/%3#&+M+?D=:4%B/3*:%3!:45*#A/63?#. _#*G/,

    =!:

    =!+6:/@+%/%%D1Pre-Analytic Systems Manager (PSM)(1)+#%#4+)#3:!:1cobas e

    41. -/6*:45*:#%#4+)#3:!:?l cobas e 4111:

    -/:EK:@+1:635!'A%:

  • 7/23/2019 3193 Instruction RU e411

    42/379

    Roche DiagnosticsA-28 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    \X7)',+,!27,%)',cobas e 411

    ^3)$%'C-3J+/+3'1C-)3)+-:C

    V%#4+)#3:!cobas e 411@:63'=/%?*#A/63?/@+6*:?:,+N3#3+?%:,6+63/1D.

    P#)4+A+B1/G@'@?'1B*:%F+

  • 7/23/2019 3193 Instruction RU e411

    43/379

    Roche DiagnosticsA-29 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    \X7)',+,!27,%)',cobas e 411

    ^3)$%'/8)3)+-:/

    Z4/@'MH+,!+6'%:*=:*#)D?#/3@+6*:?'M6+63/1'#%#4+)#3:!#cobas e411:

    53). A-6 cobase 411 (6.$2'

  • 7/23/2019 3193 Instruction RU e411

    44/379

    Roche DiagnosticsA-30 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    L)6:)+"+%E020%"6E

    =%:,%1-1+C)3)+-:C

    b3#

  • 7/23/2019 3193 Instruction RU e411

    45/379

    Roche DiagnosticsA-31 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    `)

  • 7/23/2019 3193 Instruction RU e411

    46/379

    Roche DiagnosticsA-32 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    `)

  • 7/23/2019 3193 Instruction RU e411

    47/379

    Roche DiagnosticsA-33 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    `)

  • 7/23/2019 3193 Instruction RU e411

    48/379

    Roche DiagnosticsA-34 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    `)4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++61. h4#?'3 ]:@'45j=!#?4/%+B.

    53). A-11 K'67)97&:"

  • 7/23/2019 3193 Instruction RU e411

    49/379

    Roche DiagnosticsA-35 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    L)6:)+"+%E020%"6EW!"$%'):2%,+2.

    5/G%Q3;,--$2PQ/+-27,3+/138

    P#E:A+,=/!/*4MA#3/45=+3#%+B!#6=:4:G/%%#%+G%/,4/?:,=/!/@%/,

    63:!:%/#%#4+)#3:!#. 26=:45)',3/!#E:A+,=/!/*4MA#3/45 @4B?D*4MA/%+B

    #%#4+)#3:!#6&/45M?D=:4%/%+B:=!/@/4/%%DK=!:&/@'!:E64'G+?#%+B, +4+

    /64+6+63/1#%/+6=:45)'/36B?3/A/%++'?/4+A/%%DK=/!+:@:??!/1/%+(%#=!+1/!, ?3/A/%++%:A+). P#E:A+,=/!/*4MA#3/45=+3#%+B3#*G/?D*4MA#/3

    =+3#%+/6/%6:!%:

  • 7/23/2019 3193 Instruction RU e411

    50/379

    Roche DiagnosticsA-36 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    L)6:)+"+%E020%"6EW!"$%'):2%,+2.

    A O753)+:&.1"-.=

    53). A-13 O753)+:&.1"-.=

    B Q"3+)9&.1"-.=

    [":G2-,3+/138J+/+3'1%L%G2%$/

    -#4/?:,63:!:%/N3#3+?%:

  • 7/23/2019 3193 Instruction RU e411

    51/379

    Roche DiagnosticsA-37 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    H:"=2^2$,=22020%"6E

    @,-?3>3$/?33)3)+-:C

    [-Y13Q-)$/831>%:/?38

    8#%/45,!#6=:4:G/%%#B%#=!#?:,63:!:%/#%#4+)#3:!#, 6:@/!G+3%:1/!

    A#63+, 6/!+,%D,%:1/!+3!/E:?#%+B*R4/*3!:=+3#%+M.

    Z4/@'MH+,!+6'%:*=!/@63#?4B/36:E:,=!+1/!3#*:,=#%/4+#%#4+)#3:!#.

    53). A-15 V:.5+:&"-+)."-").4"1':"

    5/4:-C31)+":-1+/

    Z4/@'MH#B3#E4+:@/!G+3!#)1/!D#%#4+)#3:!#cobas e 411, *#*@4B

    @+6*:?:,, 3#*+@4BN3#3+?%:,6+63/1D:

    R1/234/+% TC)%+/ N2"G31/ e331/ TC)%+/

    31.4@(a)

    80 61

    (a)

    (43 @, 109 616:3*!D3:,?/!K%/,*!DN*:,)31.4 @(a)80 61(a)

    (43 @+4+109 61Z:3*!D3:,?/!K%/,*!DN*:,)

    28.7 @73

    6137.4 @(b)

    95 61(b)

    47.2 @

    120 6167 @170

    61

    397 F

    180 *

  • 7/23/2019 3193 Instruction RU e411

    52/379

    Roche DiagnosticsA-38 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    H:"=2^2$,=22020%"6E

    _2-$+3Q-)$3-),-?3>3$/?33

    Z4/@'MH#B3#E4+=/!/A+64B/33!/E:?#%+M*R4/*3!:=+3#%+M+

    3/=4:?D@/4/%+M#%#4+)#3:!#cobas e 411:

    _!/E:?#%+B*'63#%:?*/: 2%63!'1/%36:?1/63+163!/E:?#%+B1=:E/):=#6%:63+IEC 61010-1, 2B!/@#*&+B; IEC 61010-

    2-081, 1B!/@#*&+B; IEC 61010-2-101, 1B!/@#*&+B;

    UL 61010-1, 2B!/@#*&+B; CAN/CSA C22.2 No.

    61010-1:2004. Z3/=/%5)#

    \#3/

  • 7/23/2019 3193 Instruction RU e411

    53/379

    Roche DiagnosticsA-39 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    H:"=2^2$,=22020%"6E

    TD@/4/%+/3/=4#(=!+1/!%:):

    2879 kJ/hresp.

    688 kcal/hresp.

    2730 Btu/h

    3778 kJ/hresp. (d3#3+?%D,1:@'45: 899 kJ/hr resp)903 kcal/hresp. (d3#3+?%D,1:@'45: 215 kcal/hr

    resp.) 3583 Btu/h (d3#3+?%D,1:@'45: 853 Btu/hr)

    [/G23?/A-2 W)+21:.E+$2.+$&+I.Y.2"I..

    ])2%'38%$"B/PM-;)-(C

    V%#4+)#3:! cobas e 411 !#)!#E:3#% @4B +6=:45):?#%+B 3:45*: ?%'3!+

    =:1/H/%+B. Z4/@'MH#B 3#E4+ 6:@/!G+3 =!+/14/1D/ @+#=#):%D =#!#1/3!:?

    :*!'G#MH/, 6!/@D, =!+ *:3:!DK #%#4+)#3:!D cobas e 411 F'%*&+:%+!'M3

    %#@/G%:+3:A%::

    _/1=/!#3'!#: P#E:3#: 18 - 32Co!#%/%+/+3!#%6=:!3+!:?*#: -20 to 75C

    2)1/%/%+/3/1=/!#3'!D:

    T4#G%:635(+6=:45):?#%+/3:45*:?%'3!+=:1/H/%+B):

    ]#*6+1'1 2C/h

    P#E:3#: 20 - 80% (*:%@/%6#&+B:36'363?'/3)

    o!#%/%+/+3!#%6=:!3+!:?*#: 5- 95%

    (:36'363?+/*:%@/%6#&++,

    E

    [/G23?/A-4 Z:'75"

  • 7/23/2019 3193 Instruction RU e411

    54/379

    Roche DiagnosticsA-40 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    H:"=2^2$,=22020%"6E

    9)+%Q13$'%(C

    Z4/@'MH#B3#E4+:@/!G+33!/E:?#%+B*?:@B%:1'6%#EG/%+M:

    \:%3/,%/!@4B?:@D: 34

    _!/E:?#%+B*?:@/: < 10 1*Z1/61+4+> 0.1 ]I1, 6?:E:@%#B

    :3E#*3/!+,(@:E#?4B/36BSysWash 6

    !#)E#?4/%+/1100+1)

    8:3!/E4/%+/?:@D: 3 4%#250 4+3!:?

    (6!/@%//): 12 14/&+*4

    [/G23?/A-5 R'6=-'+$-"3*+-.+

    f3($3-%+Y%(C

    \:%3/,%/!@4BG+@*+K:3K:@:?:

    T1/63+1:635: 4 4, 6@/3/*3+!:?#%+/1=/!/=:4%/%+B.

    [/G23?/A-6 [.62.+'1@'6?

    L)+%"T+"'

    2)1/!/%+/#%#4+):?: >: 86 3/63:?/ A#6

    [/G23?/A-8 V:'&7$2-"=$&'$'3-'$19

    @3)+-:/,--1%)$3%G/4?%'

    Z4/@'MH#B3#E4+:@/!G+36=/&+F+*#&++@4B6+63/1D=/!/%:6*+:E!#)&:?.

    I=!/@/4/%%D/=#!#1/3!D?1/63+1:63+?#!5+!'M36B1/G@'@+6*:?:,+

    N3#3+?%:,6+63/1#1+.

  • 7/23/2019 3193 Instruction RU e411

    55/379

    Roche DiagnosticsA-41 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 2726(921-$ 2E59-$&(&1";>

    H:"=2^2$,=22020%"6E

    8!+%&+=!/#

    =:)+&+,

    T6/

  • 7/23/2019 3193 Instruction RU e411

    56/379

    Roche DiagnosticsA-42 5"$%'%()+'%%,-

    ',7'.

  • 7/23/2019 3193 Instruction RU e411

    57/379

    Roche DiagnosticsA-43 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    H:"=2^2$,=22020%"6E

    D)+/+%Q1C;%Gc-:((3)$%'/8)3)+-:/)

    Z4/@'MH#B3#E4+=/!/A+64B/3:63#3:A%D/:Ei/1D@4B@4B!#)4+A%DK

    ?#!+#%3:?*:%3/,%/!:?:E!#)&:?. b3+&+F!D=!+1/%+1D3:45*:*

    @+6*:?D16+63/1#1.

    =%1+-;1-(28%G/4?%' TC)%+/,%G3$3 `%:/271/8 ]:-17J-11/8

    Z3#%@#!3%#BHitachi =!:E+!*#%#@+6*/:E!#)&:?:

    Z3#%@#!3%#BHitachi =!:E+!*#%#=/!?+A%:,=!:E+!*/(16 11@+#1/3!):

    Z3#%@#!3%#BHitachi =!:E+!*#%#=/!?+A%:,=!:E+!*/(dia. = 16 11):

    8/!?+A%#B=!:E+!*#:E!#)&:?(13 11@+#1/3!):

    8/!?+A%#B=!:E+!*#:E!#)&:?(13 11@+#1/3!):

    8/!?+A%#B=!:E+!*#:E!#)&:?(16 11@+#1/3!):

    8/!?+A%#B=!:E+!*#:E!#)&:?(16 11@+#1/3!):

    X1*:635*#4+E!#3:!#/*:%3!:44/!#:

    D)+/+%Q1C;%Gc-: D)+/+%Q1C;%Gc-:

    200 1*4 100 1*4

    75 11 200 1*4 150 1*4

    100 11 200 1*4 150 1*4

    75 11 600 1*4

    100 11 600 1*4

    75 11 1000 1*4

    100 11 1000 1*4

    150 1*4(a)

    [/G23?/A -10G$1"1'E-?B'3\+52'-1+B-+:"'3:"4I')X',7=)/2!2'",$=2)++,.:')X2'$,1"1.

  • 7/23/2019 3193 Instruction RU e411

    58/379

    Roche DiagnosticsA-44 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    H:"=2^2$,=22020%"6E

    N7,/2026)0%2)%)Xh"6)/)X',7=)/2%2:)/"6$)0%"T(+,:'26"', :"'/29+,.:')X2'$,

    )X',7=)/2!2'",$=2)++,.:')X2'$,

    H20%"6+E"'",D"+%E Z4/@'MH#B3#E4+:@/!G+36=/&+F+*#&++@4B6+63/1%DK!/#

  • 7/23/2019 3193 Instruction RU e411

    59/379

    Roche DiagnosticsA-45 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    H:"=2^2$,=22020%"6E

    94:-3+-271/8)3)+-:/

    Z4/@'MH#B3#E4+:@/!G+36=/&+F+*#&++@4B+)1/!+3/45%:,6+63/1D:

    2)1/!+3/45%D,1/3:@:

    P/G+1*#4+E!:?*+:

    ProCell =:3!/E4/%+/

    CleanCell =:3!/E4/%+/

    T!/1B&+*4#:

    _/1=/!#3'!#:

    2%3/

    2-3:A/A%#B*#4+E!:?*#

    8!+1/!%:2 14%#&+*4

    8!+1/!%:2 14%#&+*4

    42 6

    28C 2C

    [/G23?/A-15 J45+:.1+)9-"=$.$1+5"

    H%("27",/'2-138

    Z4/@'MH#B3#E4+:@/!G+36=/&+F+*#&++@4B1:@'4B'=!#?4/%+B:

    _+=:

    o!#%+4+H/@#%%DK:

    Z+63/1%D,+%3/!F/,6:

    j=!#?4BMH+,+%3/!F/,6:

    T%/N%+,=!+%3/!:

    ]:%+3:!66/%6:!%D1R*!#%:1:

    I=/!#&+:%%#B 6+63/1#

    2%3/

    *:11'%+*#&+:%%DK'63!:,63?('@#4/%%D,@:63'=, cobas Link)

    CCITT V. 24/RS-232-C (@?'%#=!#?4/%%D,)

    j=!#?4BMH#B6+63/1#@:4G%#6::3?/363?:?#353!/E:?#%+B1IEC (60950)

    Z:/@%+%/%+/A/!/)USB =:!3

    e >4B@#45%/,N/,+%F:!1#&+++6=+6*#!/*:1/%@'/1DK

    1:@/4/,=!+%3/!#, 61.N+"_+2T:'2+%"'%#63!. A-58.

    39 61(15 @) &?/3%:,TFT-LCD, XGA

    Microsoft Windows XP (?63!:/%%#B:=/!#&+:%%#B6+63/1#)

    [/G23?/A-16 Z&:":=:4%+3/45%'M+%F:!1#&+M61. ? h4#?/3`)

  • 7/23/2019 3193 Instruction RU e411

    60/379

    Roche DiagnosticsA-46 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    H:"=2^2$,=22020%"6E

    _+3$-+$3$%1+-;1-/1/G%/-/L-1+%'

    P/#

  • 7/23/2019 3193 Instruction RU e411

    61/379

    Roche DiagnosticsA-47 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    H:"=2^2$,=22020%"6E

    5-/L-1+1C-$/))-+C

    Z4/@'MH+,!+6'%:*=:*#)D?#/3=!+1/!!/#

    Z/!+,%D/%:1/!#*#4+E!#3:!:?+%#)%#A/%%D/)%#A/%+B

    Z!:*

  • 7/23/2019 3193 Instruction RU e411

    62/379

    Roche DiagnosticsA-48 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    H:"=2^2$,=22020%"6E

    Z4/@'MH#B+%F:!1#&+B1:G/3ED35+@/%3+F+&+!:?#%#%#*#G@:,R3+*/3*/

    !/#

  • 7/23/2019 3193 Instruction RU e411

    63/379

    Roche DiagnosticsA-49 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    H:"=2^2$,=22020%"6E

    `/G%C$/23G/+%%'

    >4BE:45N+%63?#3/63:?, *#4+E!#3:!D@4B!/#+5

    7&"2'

  • 7/23/2019 3193 Instruction RU e411

    64/379

    Roche DiagnosticsA-50 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    H:"=2^2$,=22020%"6E

    =/+%Q$3J+3Y-$%(%'$/23G/+%%'

    \#G@D,%#E:!*#4+E!#3:!:?=:63#?4B/36B6N3!+K-*:@*#!3:A*:,. b3#*#!3:A*#?

    F:!1#3/PDF417 +@:4G%#+6=:45):?#356B66::3?/363?'MH+1+*#4+E!#3:!#1+.

    2%F:!1#&+B, )#*:@+!:?#%%#B?*#!3:A*#KN3!+K-*:@:?*#4+E!#3:!:?(6=+6:*

    6:@/!G+3%/?6M?:)1:G%'M+%F:!1#&+M): -:1/!3/63#

    -:1/!6/!++*#4+E!#3:!#

    Z/!+,%D,%:1/!*N3!+K-*:@R3+*/3*#1*#4+E!#3:!:?

    \#*+/*#4+E!#3:!D@:4G%D+6=:45):?#356B+*:4+A/63?::=!/@/4/%+,@4B%+K.

    r/4/?D/+4+%#)%#A/%%D/)%#A/%+B

    Z!:*

  • 7/23/2019 3193 Instruction RU e411

    65/379

    Roche DiagnosticsA-51 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    H:"=2^2$,=22020%"6E

    `/G%C$%1+%2-;

    >4BE:45N+%63?#3/63:?, *:%3!:4+@4B!/#

  • 7/23/2019 3193 Instruction RU e411

    66/379

    Roche DiagnosticsA-52 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 2DG4%)3)+-:C

    H:"=2^2$,=22020%"6E

    e+3Y-$%($/+%Q$3$%1+%2-;

    \#G@D,%#E:!*:%3!:4/,=:63#?4B/36B6N3!+K-*:@*#!3:A*#1+. b3+*#!3:A*+

    3#*G/=!/@63#?4/%D?F:!1#3/PDF417 +@:4G%D+6=:45):?#356B6

    6::3?/363?'MH+1+*:%3!:4B1+. -+G/=!/@63#?4/%#A#635(3./. 1:G/3ED35

    E:45N/) +%F:!1#&++, *:@+!'MH/,6B?N3!+K-*:@*#!3:A*#K: -:1/!3/63#

    -:1/!6/!++*:%3!:4B

    \:@*:%3!:4B(%#=!+1/!, PC U1)

    2@/%3+F+*#3:!6/!++@4BN3!+K-*:@R3+*/3:*.

    r/4/?D/+4+%#)%#A/%%D/)%#A/%+B

    \:%3!:45%D/@+#=#):%D

    >#3#+63/A/%+B6!:*#

  • 7/23/2019 3193 Instruction RU e411

    67/379

    Roche DiagnosticsA-53 5"$%'%()+'%%,-/+%/ T-)381.0

    2DG4%)3)+-:C cobas e 411 /1/234/+%

    H:"=2^2$,=22020%"6E

  • 7/23/2019 3193 Instruction RU e411

    68/379

    Roche DiagnosticsA-54 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 3H%("27",/'2-138

    H%("27",/'2-138

    b3#

    a+64:?#B*4#?+#3'!# .................................................................................. 56

    8:4%#B*4#?+#3'!# ...................................................................................... 57

    8!:)!#A%:635*4#?+#3'!D .............................................. ......................... 57

    o!#%+4+H/@#%%DK ......................................................................................... 58

    T%/N%+,=!+%3/! ............................................................................................ 58

    Z/!?+6%D,+%3/!F/,6 ...................................................................................... 59

    j=!#?4BMH+,+%3/!F/,6................................................................................ 59

    I6%:?D=!:

    Z3#3'6%#B63!:*# .............................................................................................. 61

    8:@6*#)*# ......................................................................................................... 61

    b*!#%D

  • 7/23/2019 3193 Instruction RU e411

    69/379

    Roche DiagnosticsA-55 5"$%'%()+'%%,-/+%/ T-)381.0

    )obas e 411 /1/234/+% 3 H%("27",/'2-138

    j!:?%+@:63'=#*R*!#%#1 ................................................................................. 66

    Z+63/1#2%3/!#*3+?%:,8:1:H+.......... ............................................. ........ 67

  • 7/23/2019 3193 Instruction RU e411

    70/379

    Roche DiagnosticsA-56 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 3H%("27",/'2-138

    L)6:)+"+%E

    =%:,%1-1+C

    ]:@'45'=!#?4/%+B6:63:+3+)64/@'MH+K*:1=:%/%3:

    r?/3%:,1:%+3:!66/%6:!%D1R*!#%:1

    \4#?+#3'!#

    o!#%+4+H/@#%%DK

    T%/N%+,=!+%3/!

    Z/!?+6%D,+%3/!F/,6

    j=!#?4BMH+,+%3/!F/,6

    H%13+%))-1)%1C:V$/1%:

    39 61(15@) &?/3%:,1:%+3:!66/%6:!%D1R*!#%:1!#6=:4:G/%?4/?:,?/!K%/,

    A#63+#%#4+)#3:!#++6=:45)'/36B@4B:

    I3:E!#G/%+B+%F:!1#&++ -#?+

    +6=:45):?#%++ 6/%6:!%:

    6=+6:*, 3/*63:?:/=:4/+4+*%:=*') @4B?D=:4%/%+B?#N/,)#@#A+. -#=!+1/!,

    @4B:3:E!#G/%+BR*!#%#IE):!>#%%DK?1/%MP#E:A//]/63:, ?DE/!+3/

    P#E:A//]/63:, #)#3/1?DE/!+3/)#*4#@*'IE):!>#%%DK.

  • 7/23/2019 3193 Instruction RU e411

    71/379

    Roche DiagnosticsA-57 5"$%'%()+'%%,-/+%/ T-)381.0

    3 H%("27",/'2-138 cobas e 411 /1/234/+%

    L)6:)+"+%E

    53). A-22 ]+-$':-?B/2:"-

    K%L/::1/8$2/'3/+"/

    8!:

    F3)2%'/8$2/'3/+"/

    A Q-'&2":+*.5"

    &')-'B

    2)"

  • 7/23/2019 3193 Instruction RU e411

    72/379

    Roche DiagnosticsA-58 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 3H%("27",/'2-138

    L)6:)+"+%E

    K%21/8$2/'3/+"/

    A Q-'&2"&:'4:"E-'$1. B Q-'&2":+*.5"E.$)'

    =:4%:,*4#?+#3'!:,+A+64:?:,*4#?+#3'!:,.

    K%4/Q1%)+7$2/'3/+"C

    TD1:G/3/'=!#?4B35=!:)!#A%:635M=!:

    *4#?+#3'!:,, E/)%/:EK:@+1:63+:3:@?+

  • 7/23/2019 3193 Instruction RU e411

    73/379

    Roche DiagnosticsA-59 5"$%'%()+'%%,-/+%/ T-)381.0

    3 H%("27",/'2-138 cobas e 411 /1/234/+%

    L)6:)+"+%E

    g/1-13-(/11CY

    Z+63/1#+6=:45)'/3F4RN-=#1B35, *#!3:A*+=#1B3+, +CD-ROM @4BK!#%/%+B

    @#%%DK. +)+A/6*:

    >#%%D/4::20000 @%/?%DKE4:*:?6+:1000 4::180 4:

    8!+6:/@+%+3/=!+%3/!*USB =:!3', 1#!*+!:?#%%:1'PRINTER %#4/?:,63:!:%/

    #%#4+)#3:!#. Z1. %#64/@'MH/1!+6'%*/!#6=:4:G/%+/@#%%:

  • 7/23/2019 3193 Instruction RU e411

    74/379

    Roche DiagnosticsA-60 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 3H%("27",/'2-138

    L)6:)+"+%E

    53). A-25 "$&')'*+-.+&':1'@-'3)1C;31+->-;)

    Z/!?+6%D,=:!3+6=:45)'/36B@4B=!+6:/@+%/%+B?%/N%/-;)

    2%63!'1/%31:G/3ED356?B)#%6'=!#?4BMH/,6+63/1:,=:@?'%#=!#?4/%%:1'

    +%3/!F/,6'.

    Z?BG+3/656_/K%+A/6*:,8:@@/!G*:,Roche @4B=:4'A/%+B+%F:!1#&++

    +4+=:1:H+=:+6=:45):?#%+M#%#4+)#3:!#cobas e 411 6'=!#?4BMH/,

    6+63/1:,.

  • 7/23/2019 3193 Instruction RU e411

    75/379

    Roche DiagnosticsA-61 5"$%'%()+'%%,-/+%/ T-)381.0

    3 H%("27",/'2-138 cobas e 411 /1/234/+%

    \0+)/E:')D',66+)D))X"0:"9"+2.

    D)1%'C,%L/::1%L%%G-),-Q-138

    b3# 6/*&+B 6:@/!G+3 :E):! 6+63/1%::=+6#%+/164/@'MH+KR*!#%%DKR4/1/%3:?:

    Z3#3'6%#B63!:*#

    8:@6*#)*#

    b*!#%D4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++61. 6/*&+M8!:

    2%3/!#*3+?%:,8:1:H+.

    H$'2+_)%E, 0)

  • 7/23/2019 3193 Instruction RU e411

    76/379

    Roche DiagnosticsA-62 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 3H%("27",/'2-138

    \0+)/E:')D',66+)D))X"0:"9"+2.

    @+/+")1/8)+%$/

    Z3#3'6%#B63!:*#:3:E!#G#/36B%#?/!K'*#G@:?:,%#B+*:%*#63#3'6#64/?#+)1/%B/3&?/3@4B:3!#G/%+B3/*'H/

  • 7/23/2019 3193 Instruction RU e411

    77/379

    Roche DiagnosticsA-63 5"$%'%()+'%%,-/+%/ T-)381.0

    3 H%("27",/'2-138 cobas e 411 /1/234/+%

    \0+)/E:')D',66+)D))X"0:"9"+2.

    _$/1CL2/'1%L%:-1P

    h!#F+A/6*+,=:45):?#3/456*+, +%3/!F/,6, +6=:45)'/1D,?1:@'4/'=!#?4/%+B,

    6:63:+3+)N/63+:6%:?%DKR*!#%:?:

    IE):!6+63/1D(System Overview)

    P#E:A//1/63: (Workplace)

    P/#4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.Q)!?7)/,%"!?0$2"J')/+2

    DG4%)3)+-:C(System Overview)

    b*!#%Z+63/1%D,IE):!(System Overview) B?4B/36B&/%3!#45%D1R*!#%:1@4B

    ?D=:4%/%+B=:?6/@%/?%DK:=/!#&+,. I36M@#?D1:G/3/=!:61#3!+?#3563#3'6

    !/#5/G%Q--:-)+%(Workplace)

    b*!#%P#E:A//]/63:(Workplace) 6:63:+3+)@?'K:6%:?%DK)#*4#@:*: TDE:!_/63:?

    (Test Selection) +IE):!>#%%DK(Data Review).

    TDE:!_/63:?(Test Selection) +6=:45)'/36B@4B??:@#+=!:61:3!#?DE:!*+3/63:?

    @4B:E!#).

    IE):!>#%%DK(Data Review) +6=:45)'/36B@4B=:+6*#, :E):!#,!/)/!?+!:?#%+B,

    '@#4/%+B+=:6D4*+@#%%DK*'=!#?4BMH/,6+63/1/.

    e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.%"'(*++-+./(Workplace menu) ?

    6/*&++:=+6#%+B=!:

    5-/L-1+C(Reagent)

    b*!#%]/%MP/#

  • 7/23/2019 3193 Instruction RU e411

    78/379

    Roche DiagnosticsA-64 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 3H%("27",/'2-138

    =/23G%'$/(Calibration)

    QC

    ]+323+/(Utility)

    O/$2/($3H-1P

    K%28),3)$%'

    \0+)/E:')D',66+)D))X"0:"9"+2.

    b*!#%1/%M\#4+E!:?*#(Calibration) 6:63:+3+)3!/K)#*4#@:*: Z3#3'6(Status,

    \#4+E!#3:!D(Calibrator) +j63#%:?*#(Install). I%++6=:45)'M36B @4B)#=!:6#

    *#4+E!:?:*, '63#%:?*+*#4+E!#3:!:? , +=!:61:3!#!/)'453#3:?*#4+E!:?:*.

    e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.`"+PL,!2X')/$,(Calibration

    menu) ?6/*&++:=+6#%+B8!:

    b*!#%1/%MQC 6:63:+3+)N/63+)#*4#@:*: Z3#3'6(Status), Z3#3'6TD=:4%/%+B

    (Run Status), 2%@+?+@'#45%D/(Individual), \'1'4B3+?%D/(Cumulative),

    \:%3!:45(Control) +j63#%:?*#(Install). 26=:45)',3/R3+R*!#%D@4B'63#%:?*+,

    =!:61:3!#+!/@#*3+!:?#%+B*:%3!:4/,, :&/%*++#**'1'4+!:?#%+B!/)'453#3:?

    *:%3!:4B*#A/63?#

    e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.`"+PQC (QC menu) ?6/*&++

    :=+6#%+B8!:

    b*!#%1/%Mj3+4+3#(Utility) 6:63:+3+)A/3D!/K)#*4#@:*: Z+63/1#(System),

    IE64'G+?#%+/(Maintenance), 8!+4:G/%+/(Application) +TDA+64B/1D,_/63

    (Calculated Test). b3+R*!#%D+6=:45)'M36B@4B??:@#6+63/1%DK%#63!:/*,

    =#!#1/3!:?=!+4:G/%+,+@:63'=#*F'%*&+B1:E64'G+?#%+B+6/!?+6#.

    e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.`"+PS%2!2%,(Utility Menu)

    ?6/*&++:=+6#%+B8!:

    TD1:G/3/+6=:45):?#35)#*4#@*+1/%M, @4B?DE:!#R*!#%:?+:*:%

    6

    e#*4#@*+1/%M=B35: P#E:A//]/63:(Workplace), P/#

    :=!/@/4/%%:1%#=!#?4/%++. _/*'H+,?DE:!'*#)D?#/36B*'!6:!:1?DE:!#

    =:@6?/3*:,. TD1:G/3/3#*G/+6=:45):?#35*4#?+N+Home, End, Page Up, +Page

    Down %#=:4%:,=!:

    3!/E'/1D,R4/1/%3E'@/3?D@/4/%, %#G1+3/Enter (??:@).

  • 7/23/2019 3193 Instruction RU e411

    79/379

    Roche DiagnosticsA-65 5"$%'%()+'%%,-/+%/ T-)381.0

    3 H%("27",/'2-138 cobas e 411 /1/234/+%

    \0+)/E:')D',66+)D))X"0:"9"+2.

    [-$)+%'C-,%28

    =1%,$3%,?3;

    =1%,$3

    _/*63:?:/=:4/ =:)?:4B/3??:@+35+%F:!1#&+M. -/*:3:!D/3/*63:?D/=:4B

    +6=:45)'M36B@4B:3:E!#G/%+B+%F:!1#&++. >!'

    \:6%+3/65R3:,*%:=*+@4B)#*!D3+B:*%#.

  • 7/23/2019 3193 Instruction RU e411

    80/379

    Roche DiagnosticsA-66 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 3H%("27",/'2-138

    H)Y',+2%?(Save)

    \X+)/2%?(Update)

    H%',+29+E"$+):$2

    (Page Buttons)

    \0+)/E:')D',66+)D))X"0:"9"+2.

    \:6%+3/65R3:,*%:=*+@4B6:K!#%/%+B4MEDK+)1/%/%+,, 6@/4#%%DK?3/*'H/1

    :3:E!#G#/1:1R*!#%//:*%/. 8:64/?D=:4%/%+B+)1/%/%+,, *%:=*#63#%:?+36BG/43:,.

    \:6%+3/65R3:,*%:=*+@4B:E%:?4/%+B@#%%DK, *:3:!DK*#6#M36B

    =!:+)?:@+1D/?3/*'H/1R*!#%//:*%/+)1/%/%+B. 8:64/?D=:4%/%+B

    +)1/%/%+,, *%:=*#63#%:?+36BG/43:,.

    -/*:3:!D/R*!#%D+1/M363!#%+A%D/*%:=*+, *:3:!D/1:

  • 7/23/2019 3193 Instruction RU e411

    81/379

    Roche DiagnosticsA-67 5"$%'%()+'%%,-/+%/ T-)381.0

    3 H%("27",/'2-138 cobas e 411 /1/234/+%

    \0+)/E:')D',66+)D))X"0:"9"+2.

    D$1/

    \$+,

    :)+#=#):%#IE!#)&:?(Sample Range Start). -#)?#%+/*%:=*+

    +)1/%+356B %# \:%/& >+#=#):%# IE!#)&:? (Sample Range End) + &?/3 //

    +)1/%+356B%#E/4D,.

    3 TDE/!+3/=:64/@%+,:E!#)/&6=+6*#+)6=+6*#64/?#R*!#%#. 26=:45)',3/

    =:4:6D=!:*!'3*+@4B:3:E!#G/%+B:E!#)&:?, *:3:!D/%#K:@B36B?%+)' 6=+6*#.

    4 \:6%+3/65\:%/&>+#=#):%#IE!#)&:?(Sample Range End). TDE!#%%D/

    :E!#)&D=:@6?/3B36B6+%+1F:%:1.

    ]%'13(%)+",/$V$/1/:

    >:63'= * %/*:3:!D1 R*!#%#1, :6:E/%%: * 3/1, *:3:!D/ %#K:@B36B ? 1/%M j3+4+3#

    (Utility), :

    '!:?%B @:63'=# :=/!#3:!#, 4+E: %/ 1:

  • 7/23/2019 3193 Instruction RU e411

    82/379

    Roche DiagnosticsA-68 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 3H%("27",/'2-138

    \0+)/E:')D',66+)D))X"0:"9"+2.

    @3)+-:/91+-/$+3'1%;,%:%M3

    cobas e 411 +1//3*:%3/*63%:-A'?63?+3/45%'M+%3/!#*3+?%'M=:1:H5, *:3:!#B

    1:G/364'G+35=:1:H%+*:1=!+R*6=4'#3#&++6+63/1D. \:%3/*63%:-

    A'?63?+3/45%#B :)%#A#/3, A3:=!+4:G/%++cobas e 411, ?DE:!F'%*&+M=:1:H+:3:E!#G#/3?6=:1:

  • 7/23/2019 3193 Instruction RU e411

    83/379

    Roche DiagnosticsA-69 5"$%'%()+'%%,-/+%/ T-)381.0

    3 H%("27",/'2-138 cobas e 411 /1/234/+%

    \0+)/E:')D',66+)D))X"0:"9"+2.

  • 7/23/2019 3193 Instruction RU e411

    84/379

    Roche DiagnosticsA-70 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    =%:,%1-1+C/1/234/+%/

    b3#

  • 7/23/2019 3193 Instruction RU e411

    85/379

    Roche DiagnosticsA-71 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    \:1=:%/%3D+)1/!+3/45%:,:E4#63+ .................................................................. 97

    2%*'E#3:!.......................................................................................................... 97

    Z+==/!%D,):%@+=!:1D?:A%#B63#%&+B ..................................................... 98

    Z+==/!%D,=+=/33/! .............................. ............................................. ........ 99

    Z+63/1%D/!/#

  • 7/23/2019 3193 Instruction RU e411

    86/379

    Roche DiagnosticsA-72 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    \X7)'$)6:)+"+%,+,!27,%)',

    DG4%$%:,%1-1+/1/234/+%/

    \:1=:%/%3D#%#4+)#3:!#cobas e 411,!#)1/H#MH+/6B?!#)4+A%DK:E4#63BK:

    IE4#635IE!#)&:?/P/#+6*IE!#)&:?

    d3#3+?%D,E4:*

    e:%@(S/R) :E!#)&:?/!/#

  • 7/23/2019 3193 Instruction RU e411

    87/379

    Roche DiagnosticsA-73 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    =%:,%1-1+C%G2/)+3%G/4?%'/-/L-1+%'

    IE4#635:E!#)&:?/!/#

  • 7/23/2019 3193 Instruction RU e411

    88/379

    Roche DiagnosticsA-74 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    ^3)$%G/4?%'

    >+6*:E!#)&:?+1//330 =:)+&+,@4B:E!#)&:?, *#4+E!#3:!:?+*:%3!:4/,. TD

    1:G/3/=:1/H#35:E!#)&D=#&+/%3:?4+E:?=/!?+A%D/=!:E+!*+:E!#)&:?,

    4+E:?=!:E+!*+:E!#)&:?. T63!:/%%D/#@#=3/!D=:)?:4BM361/N+?#35

    =/!?+A%D/=!:E+!*+!#)4+A%DK!#)1/!:?.

    e >/3#4+=:+6=:45):?#%+M=/!?+A%DK=!:E+!:*61. ?!#)@/4/H20%"6,\X',7=)/

    %#63!. A-40.

    TD1:G/3/=:1/H#35=!:E+!*+:E!#)&:?[3:45*:2 14(Z3#%@#!3%D/)

    Hitachi =!:E+!*+] =!B1:%#@+6*:E!#)&:?, 4+E:%#?/!N+%'16 11

    =/!?+A%DK=!:E+!:*.

    c!.:)!J9"+2.)X["T2+ )'6,=22:)X"7):,0+)0%2,06.

    >0:)!?7)/,+2"62$')-9,_"$+,0%'. A-17.

    53). A-31 c.$2'3:"4I'

  • 7/23/2019 3193 Instruction RU e411

    89/379

    Roche DiagnosticsA-75 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    e+/+3'1C;G2%$

    d3#3+?%D,E4:*6:63:+3+)A-4+%++, B-4+%++, C-4+%+++STAT

    (\:!:3*:-

    TK:@%:,E'F/!, =:*#)#%%D,%#64/@'MH/1!+6'%*/, +1//31/63:@4B=B3+

    @:=:4%+3/45%DKN3#3+?:?. 8:R3:1', @:E#?+?+K*15 N3#3+?#1%#A-4+%++, ?D

    =:4'A+3/?6/

  • 7/23/2019 3193 Instruction RU e411

    90/379

    Roche DiagnosticsA-76 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    53). A-33

    B-23138

    R@'6-'B37Y+:>1"1.

  • 7/23/2019 3193 Instruction RU e411

    91/379

    Roche DiagnosticsA-77 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    TCY%(1%;G">-

    d3#3+?D6

    53). A-35 R?@'6-'B37Y+:$>1"1.

  • 7/23/2019 3193 Instruction RU e411

    92/379

    Roche DiagnosticsA-78 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    C-23138

    \:1"1.

  • 7/23/2019 3193 Instruction RU e411

    93/379

    Roche DiagnosticsA-79 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    STATJ+/+3'1/8,%43?38

    STAT (\:!:3*:1"1.

  • 7/23/2019 3193 Instruction RU e411

    94/379

    Roche DiagnosticsA-80 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    e+/+3'C

    8!:E+!*+:E!#)&:?, =/!?+A%D/=!:E+!*+:E!#)&:?, /1*:63+*#4+E!#3:!:?+4+

    *:%3!:4/,=:1/H#M36B?N3#3+?D, *#*=:*#)#%: %+G/. \#G@D,N3#3+?1:G/3

    6:@/!G#351#*6+1'1=B35:E!#)&:?. \#G@D,64:3@4B=!:E+!*++1//3

    #@#=3/!D, *:3:!D/=:)?:4BM3=:1/H#35?N3#3+?=/!?+A%D/=!:E+!*+

    :E!#)&:?!#)4+A%DK!#)1/!:?. \#G@D,N3#3+?+1//3'%+*#45%D,ID,)#*:@+!:?#%%D,?N3!+K-*:@R3+*/3*/%#)#@%/,A#63+N3#3+?#. b3:3ID

    N3#3+?#6A+3D?#/36B6*#%/!:1+=/!/@#/36B?6+63/1'. I%)#3/1:3:E!#G#/36B

    *#*%#R*!#%#K3#*+?:3A/3#K.

    A M1:.@-2'6ID>1"1.

  • 7/23/2019 3193 Instruction RU e411

    95/379

    Roche DiagnosticsA-81 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    O%1((S/R) %G/4?%'/-/L-1+%'

    e:%@:E!#)&:?/!/#:=:4%+3/45%D/%#*:%/A%+*++6=:45)'M36B@4B

    !#)E#?4/%+B:E!#)&:?+=!/@?#!+3/45%:,=:@

    '",D"+%)/%#63!. A-46.

    Z*#%/!N3!+K-*:@:?#?3:-@+FF/!/&+!'MH+,, A3:=:)?:4B/3+6=:45):?#35

    !#)4+A%D/3+=DN3!+K-*:@:??:?!/1B!#E:3D. Z*#%/!3#*G/6=:6:E/%

    6A+3D?#35N3!+K-*:@DF:!1#3#PDF417.

  • 7/23/2019 3193 Instruction RU e411

    96/379

    Roche DiagnosticsA-82 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++61. L)+=":=2.F",D"+%)/(Reagent concept) ?COBI-CD.

    TD 1:G/3/ '?+@/35 6*#%/! N3!+K-*:@:? %# N3#3+?%:, 6+63/1/, /64+ '@#4/%

    !/#4B 6A+3D?#%+B N3!+K-*:@ R3+*/3:*, 6*#%/! ?!#H#/36B 1/G@'

    !/#4B=:4'A/%+B+%F:!1#&++:?3:!:16*#%/!/N3!+K-*:@:?, 61. H$,+"'_%'2Y-

    $)1:.@-2'62"1:'E2.2").3:"1':".).2'-1:')= B ])'1$2"-+:">1:.@-2'6'

  • 7/23/2019 3193 Instruction RU e411

    97/379

    Roche DiagnosticsA-83 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    A ])'1$2"-+:">1:.@-2'6'

  • 7/23/2019 3193 Instruction RU e411

    98/379

    Roche DiagnosticsA-84 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    @$/1-J+3Y-$%(%'J+/+3'%'3)-1)%%G/4?%'

    Z*#%/!N3!+K-*:@:?N3#3+?:?, 6A+3D?#/3*#*N3!+K-*:@R3+*/3*+:E!#)&:?, 3#*

    +N3#3+?:?. Z*#%/!#?3:-@+FF/!/%&+!'MH+,, A3:=:)?:4B/3+6=:45):?#35

    !#)4+A%D/3+=DN3!+K-*:@:??:?!/1B!#E:3D. -#E:!D6+1?:4:?N3!+K-*:@:?

    1::=:4%+3/45%:*6*#%/!' N3!+K-*:@:?, +1//36B3#*G/ 6/%6:!:E!#)&:?,

    *:3:!D,:=!/@/4B/3, +1//36B4+=!:E+!*#?=:)+&++N3#3+?#.

    A ])'1$2"-+:">1:.@-2'6'

  • 7/23/2019 3193 Instruction RU e411

    99/379

    Roche DiagnosticsA-85 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    @+/1?38)Q3+C'/138J+3Y-$%($/+%Q-$

    -#R3:,63#%&++, 6*#%/!N3!+K-*:@:?6A+3D?#/3+%F:!1#&+M=:

    *#4+E!#3:!#1+*:%3!:4B16+KN3!+K-*:@*#!3:A/*. b3+*#!3:A*+

    =:63#?4BM36B6%#E:!#1+*#4+E!#3:!:?+*:%3!:4/,. \:4B=:4'A/%+B@:=:4%+3/45%:, +%F:!1#&++:

    M%'2Y-$)

  • 7/23/2019 3193 Instruction RU e411

    100/379

    Roche DiagnosticsA-86 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    5-/L-1+1C;%+%

    P/#1#*6+1#45%:/*:4+A/63?:!/#

  • 7/23/2019 3193 Instruction RU e411

    101/379

    Roche DiagnosticsA-87 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    H-Y/134:%+$C+38/4/$C+38$CJ-$-/L-1+%'

    >4B=!/@:3?!#H/%+B+6=#!/%+B!/#+2:+"D+-1'

  • 7/23/2019 3193 Instruction RU e411

    102/379

    Roche DiagnosticsA-88 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    53). A-47 K.2:'>":.2'

  • 7/23/2019 3193 Instruction RU e411

    103/379

    Roche DiagnosticsA-89 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/

    K3,-++-%G/4?%'/-/L-1+%'(S/R)

    S/R =+=/33/!!#6=:4:G/%6=!#?#%#)#@%/,A#63+#%#4+)#3:!#. 8+=/33/!)#=:4%/%

    6+63/1%:,?:@:,++6=:45)'/3=:4:G+3/45%:/)#1/H/%+/@4B)#E:!#+

    ?D6?:E:G@/%+B+)S/R ):%@#

    A V.&+11+:'3:"4I'

  • 7/23/2019 3193 Instruction RU e411

    104/379

    Roche DiagnosticsA-90 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2',0Y)

  • 7/23/2019 3193 Instruction RU e411

    105/379

    Roche DiagnosticsA-91 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2',0Y)

  • 7/23/2019 3193 Instruction RU e411

    106/379

    Roche DiagnosticsA-92 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2',0Y)

  • 7/23/2019 3193 Instruction RU e411

    107/379

    Roche DiagnosticsA-93 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2',0Y)

    :)72=2)+2')/,++ET$)+%"T+"', /E7E/,"%:"'"Y)

  • 7/23/2019 3193 Instruction RU e411

    108/379

    Roche DiagnosticsA-94 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2',0Y)

  • 7/23/2019 3193 Instruction RU e411

    109/379

    Roche DiagnosticsA-95 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2',0Y)

  • 7/23/2019 3193 Instruction RU e411

    110/379

    Roche DiagnosticsA-96 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E)X!,0%2',0Y)

  • 7/23/2019 3193 Instruction RU e411

    111/379

    Roche DiagnosticsA-97 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E)X!,0%2',0Y)

  • 7/23/2019 3193 Instruction RU e411

    112/379

    Roche DiagnosticsA-98 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E276"'2%"!?+)T7)+E

    =%:,%1-1+C34:-3+-271%;4%1C

    2)1/!+3/45%#B):%#6:@/!G+364/@'MH+/*:1=:%/%3D:

    2%*'E#3:!

    Z+==/!%D,):%@+=!:1D?:A%#B63#%&+B

    Z+==/!%D,=+=/33/!

    Z+63/1%D/!/#

  • 7/23/2019 3193 Instruction RU e411

    113/379

    Roche DiagnosticsA-99 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E276"'2%"!?+)T7)+E

    @3,,-1C;4%1(3,%:C'%Q1/8)+/1?38

    Z+==/!%D,):%@)#E+!#/3!/#*&+:%%'M61/65?+)1/!+3/45%'M BA/,*', #

    3#*G/?DE+!#/3ProCell +CleanCell. P#6=:4#

  • 7/23/2019 3193 Instruction RU e411

    114/379

    Roche DiagnosticsA-100 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E276"'2%"!?+)T7)+E

    K3,-++-)3,,-/

    8+=/33/!6+==/!#!#6=:4:G/%6=!#?#:3=+=/33/!#:E!#)&:?/!/#

  • 7/23/2019 3193 Instruction RU e411

    115/379

    Roche DiagnosticsA-101 5"$%'%()+'%%,-/+%/ T-)381.0

    4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%

    L)6:)+"+%E276"'2%"!?+)T7)+E

    @3)+-:1C--/L-1+C(ProCell 3CleanCell)

    ProCell +CleanCell 6:@/!G#36B?E'3D4*#K?:E4#63+=+=/33!#, )#*:%3/,%/!:1

    @4BG+@*+K:3K:@:?.

    ProCell R3:E'F/!%D,!#63?:!, 6:@/!G#H+,3!+!:=+4#1+%(TPA). C'3D4*+

    ProCell +@/%3+F+&+!'M36B=:E/4D1*!DN*#1.

    CleanCell R3::A+H#MH+,!#63?:!, +6=:45)'/1D,@4B:A+63*+

    +)1/!+3/45%:,BA/,*+=:64/+)1/!/%+B. C'3D4*+CleanCell

    +@/%3+F+&+!'M36B=:A/!%D1*!DN*#1.

    >?/E'3D4*+*#G@:

  • 7/23/2019 3193 Instruction RU e411

    116/379

    Roche DiagnosticsA-102 5"$%'%()+'%%,-/+%/ T-)381.0

    cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/

    L)6:)+"+%E276"'2%"!?+)T7)+E

    A f"T+)2"T.12"$.&&+:" B _"3':371?)'22

    C _"3':371?)'21 D g.1'2$.&&+:"(

  • 7/23/2019 3193 Instruction RU e411

    117/379

    _$),2"/+/?38

    5 \X7)'..................................................................................... B-3

    6 Q)/0"

  • 7/23/2019 3193 Instruction RU e411

    118/379

  • 7/23/2019 3193 Instruction RU e411

    119/379

    Roche DiagnosticsB-3 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 5DG4%

    DG4%

    b3#

    P'*:?:@63?:=:R*6=4'#3#&++ ................................................................................ 5

    >+6*:?D/+N3#3+?%D/6+63/1D............................................................................. 5

    8!:

  • 7/23/2019 3193 Instruction RU e411

    120/379

    Roche DiagnosticsB-4 5"$%'%()+'%%,-/+%/ T-)381.0

    )obas e 411 /1/234/+% 5 DG4%

  • 7/23/2019 3193 Instruction RU e411

    121/379

    Roche DiagnosticsB-5 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 5DG4%

    FJ$)/)T!'*:?:@63?/=:R*6=4'#3#&++?D%#,@/3/:

    8!:&/@'!D/G/@%/?%:,R*6=4'#3#&++

    8!:&/@'!D/G/@%/?%:

    K%L/::1/8$2/'3/+"/

    8!:

    6/%6:!%:1 R*!#%/, =: 1/!/ %/:EK:@+1:63+. T )#?+6+1:63+ :3 3+=#

    ??:@+1DK @#%%DK, 1:G/3 :3:E!#G#356B 4+E: A+64:?#B *4#?+#3'!#, 4+E:

    =:4%#B.

    -#!+6'%*#K%+G/=!/@63#?4/%D:E#?+@#=!:

  • 7/23/2019 3193 Instruction RU e411

    122/379

    Roche DiagnosticsB-6 5"$%'%()+'%%,-/+%/ T-)381.0

    5DG4% cobas e 411 /1/234/+%

    Q')D',66+,.$!,/2,%J',

    53). B-2 V')-"=(372

  • 7/23/2019 3193 Instruction RU e411

    123/379

    Roche DiagnosticsB-7 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    K%')-(1-'1/8V$),2"/+/?38

    TR3:,Z=+6:*)#

  • 7/23/2019 3193 Instruction RU e411

    124/379

    Roche DiagnosticsB-8 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Z*#%+!:?#%+/N3!+K-*:@*#!3:A/**#4+E!#3:!:?+*:%3!:4/,............ 33

    e#

    V*3+?#&+BQC 3/63# .................................................................................... 36

    2)1/!/%+/*#4+E!#3:!:?+*:%3!:4/, ..................................................... 36

    8:@3?/!G@/%+/!/)'453#3:?*#4+E!:?*++*:%3!:4/,.................................. 38

    V**'1'4+!:?#%+/!/)'453#3:? QC ............................................................ 41\:!!/*3%#B'63#%:?*#13 11=!:E+!:*:E!#)&:?%#@+6*:E!#)&:? ............ 41

    \:!!/*3%#B'63#%:?*#13 11=!:E+!:*:E!#)&:?%#N3#3+? ......................... 43

    2)1/!/%+B63#%@#!3%DK:E!#)&:?: @+6*:?#B6+63/1# .................................... 45

    8!:

    +%3/!F/,6:1. ......................................................................................... 45

    8!:

    +%3/!F/,6:1 ................................................................................................ 47

    8!:

    +%3/!F/,6#................................................................................................... 48

    8!:

    +%3/!F/,6# .................................................................................................. 50

    2)1/!/%+B63#%@#!3%DK:E!#)&:?: N3#3+?%#B6+63/1# .................................. 538!:

    +%3/!F/,6:1 ............................................................................................... 53

    8!:

    +%3/!F/,6:1 ................................................................................................ 54

    8!:

    +%3/!F/,6#................................................................................................... 56

    8!:

    +%3/!F/,6#................................................................................................... 58

    2)1/!/%+/@:=:4%+3/45%DK63#%@#!3%DK:E!#)&:? ......................... ......... 60

    -/=!/!D?%#B)#

    ................................................................................................................ 62-/=!/!D?%#B)#

    V?3:1#3+A/6*:/ !#)E#?4/%+/#%#4+)#3:!:1 ............................................ 75

    I364/G+?#%+/:E!#)&:?: @+6*:?#B6+63/1# .................................................... 76

    I364/G+?#%+/:E!#)&:?: N3#3+?%#B6+63/1# ................................................. 77

    e#

  • 7/23/2019 3193 Instruction RU e411

    125/379

    Roche DiagnosticsB-9 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    P/)'453#3D .......... ............. ............. ............ ............. ........... ............. ............ .......... .... 81

    8!:61:3!!/)'453#3:?=:=#&+/%3#1 .............................................................. 82

    +453!#&+B!/)'453#3:?=:=#&+/%3#1 .......................................................... 84

    P#6=/A#3*#+4+)#

    I=&++:E4#63+TD=:4%/%+Bj64:?+,(Completion Conditions).............. 85

    I=&++:E4#63+8!+6:/@+%/%+/8!+%3/!:?(Printer Connection) . ......... 85

    I=&++:E4#63+V?3:1#3+A/6*#BP#6=/A#3*#(Automatic Printout) ......... 85

    P#6=/A#3*#I3A/3#=:P/)'453#3#1(Result Report) ................. ............ ........ 85

    j=!#?4/%+/=:63-:=/!#&+:%%D1+@#%%D1+ ....................................................... 87

    IE):!!/)'453#3:? .................................... ............................................. ........ 87

    j@#4/%+/@:*'1/%3+!:?#%%DK:E!#)&:?. ...... 87

    >%/?%:/:E64'G+?#%+/ .......................................................................................... 87

    TD*4MA/%+/#%#4+)#3:!# ...................................................................................... 88

    8!/@:3?!#H/%+/+6=#!/%+B6+63/1%DK!/#

  • 7/23/2019 3193 Instruction RU e411

    126/379

  • 7/23/2019 3193 Instruction RU e411

    127/379

    Roche DiagnosticsB-11 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    \X7)'

    DG4%

    8:?6/@%/?%#B!#E:3#?*4MA#/363#%@#!3%D/)#@#A+, *:3:!D/%/:EK:@+1:

    ?D=:4%B35@4B=:@=!/@63#?4B/3:E):!=!:&/66:?@%/?%:,!#E:3D.

    (a)Short Turn Around Time- \:!:3*:

  • 7/23/2019 3193 Instruction RU e411

    128/379

    Roche DiagnosticsB-12 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q'"

    e#1/%#%/:EK:@+1DK!/#

    e#=!:6*:%3!:4/, Z=+6:*)#

    2)1/!/%+/*#4+E!#3:!:?+*:%3!:4/, b*!#%j64:?+Be#='6*#(Start Conditions)

    8:@3?/!G@/%+/*#4+E!:?:*+!/)'453#3:?*:%3!:4/, (-/3)

    [/G23?/B- 1 ]&.$'2&:'

  • 7/23/2019 3193 Instruction RU e411

    129/379

    Roche DiagnosticsB-13 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q'"

    e#='6*:E!#E:3*+

    I364/G+?#%+/:E!#E:3*+:E!#)&:?

    (TD=:4%B/36B%#'=!#?4BMH/,6+63/1/)

    (-/3)

    b*!#%j64:?+Be#='6*#(Start Conditions)

    I*%:I364/G+?#%+/IE!#)&:?

    (Sample Tracking)

    I&/%*#!/)'453#3:?

    P#6=/A#3*#:3A/3#

    8!:61:3!!/)'453#3:?

    j@#4/%+/@:*'1/%3+!:?#%%DK:E!#)&:?

    b*!#%IE):!>#%%DK (Data Review)

    b*!#%IE):!>#%%DK (Data Review)

    b*!#%IE):!>#%%DK (Data Review)

    >%/?%:/:E64'G+?#%+/

    IA+63*#S/R):%@#

    TD=:4%/%+/:E64'G+?#%+/F+%#4+)#&++(=!+%/:EK:@+1:63+)

    TD*4MA/%+/

    (-/3)

    I*%:+%#4+)#&+B(Finalization)

    I*%:e#?/!N/%+BP#E:3D(Shutdown)

    [/G23?/B- 1 ]&.$'2&:'0:)!?7JT%"W$',+S%2!2%,(Utility) >H20%"6,(Utility > System)(Utility > System)

    8!+?*4MA/%++, ?D=:4%B/36B+%+&+#4+)#&+B, #)#3/16+63/1#=/!/K:@+3?!/G+1

    :G+@#%+B.

  • 7/23/2019 3193 Instruction RU e411

    130/379

    Roche DiagnosticsB-14 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q'"

  • 7/23/2019 3193 Instruction RU e411

    131/379

    Roche DiagnosticsB-15 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q'"

  • 7/23/2019 3193 Instruction RU e411

    132/379

    Roche DiagnosticsB-16 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q'"

  • 7/23/2019 3193 Instruction RU e411

    133/379

    Roche DiagnosticsB-17 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    K%'-$/)3)+-:1CY)3L1/271CY)%%GM-13;

    X64+ED4:

    e Z1. N$!P9"+2"%J6X!"')/:2%,+2.%#63!. B-14.

  • 7/23/2019 3193 Instruction RU e411

    134/379

    Roche DiagnosticsB-18 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q)

    =!:

    4ME:/?!/1B. b3:3R*!#%:3:E!#G#/363#3'6*#G@:

    #%#4+)#3:!#.

    9$%1$/

    j=!.6+6-1#(Host)

    i'-+

    Z+%+,

    e/4/%D,

    O1/Q-13-

    \:11'%+*#&+B6'=!. 6+63/1:,%#63:!:%/#%#4+)#3:!#cobase 411 ?D*4MA/%#(%/)#?+6+1::3@:63'=#*'=!#?4BMH/,6+63/1/).

    \:11'%+*#&+B6'=!. 6+63/1:,%#63:!:%/#%#4+)#3:!#cobase 411 ?*4MA/%#(%/)#?+6+1::3@:63'=#*'=!#?4BMH/,6+63/1/).

  • 7/23/2019 3193 Instruction RU e411

    135/379

    Roche DiagnosticsB-19 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q)

  • 7/23/2019 3193 Instruction RU e411

    136/379

    Roche DiagnosticsB-20 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q)

    R$+3'1%-(Active)

    K-(",-B(-13-(Warning)

    K-(%)+--B-13-(Caution)5-B3:%B3(/138(Standbye)

    `%27+-)+%',9),%274%'/1

    @'%G%(1/8,%4.

    K%)%Q-1.

    ^-;)+'3+-271/

    O/,%J-1/

    `-"(/2/)7

    ^-;)+'3+-2-1

    O/,%J-1

    `/"J-13-

    K%)+%Q-1.

    P/# System)(Z3!. 2/3) >

    8!:?/!*#j!:?%BP/#4B@#%%:A+64:1% %+G/. \:4:%*#PC1 =!/@63#?4B/3E'3D4*'1 +PC2 E'3D4*'2.

    h:4'E#B=#%/45'*#)D?#/3*:4+A/63?::63#MH/

  • 7/23/2019 3193 Instruction RU e411

    137/379

    Roche DiagnosticsB-21 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q)

  • 7/23/2019 3193 Instruction RU e411

    138/379

    Roche DiagnosticsB-22 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q)

    (Reagent Load List), Z=+6:*e#

    8#!#1/3!:?(Parameter Download), +I364/G+?#%+/IE!#)&:?(Sample Tracking).

    r?/3*#G@:,*%:=*+?#!5+!'/36B, ?)#?+6+1:63+:363#3'6#, TDE:!R3+K

    *%:=:*:3:E!#G#/3R*!#%D+:*%#, *:3:!D/=:)?:4BM3=:45):?#3/4B1

    =!/@=!+%+1#35@/,63?+B%/:EK:@+1D/@4B*#G@:,*:%*!/3%:,6+3'#&++.

    26=:45)',3/IE64'G+?#%+/(Maintenance) %#R*!#%/Z+63/1%:#%%DK=::E!#)(Sample Data Clear) , *:#%%DK=::E!#)(Sample Data Clear) @4B'@#4/%+B!/)'453#3:?=

    :E!#). IA+63*#>#%%DK=::E!#)(Sample Data Clear) '@#4B/3?6/)#=+6+=::E!#)+

    =/!/1/H#/3@#%%D/QC ?8!:61:3!QC (QC view). P/*:1/%@'/36B!/

    DQ3)+$/(/11CY,%DG/4?/:

    F"$)6"+!/#

  • 7/23/2019 3193 Instruction RU e411

    139/379

    Roche DiagnosticsB-23 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q)

    %#R*!#%/Z+63/1%D,IE):!. I3:E!#)+36B:*%:

    =:@3?/!G@/%+B.

    2 -#G1+3/>#@4B!#6=/A#3*+6=+6*#.

    3 e#1/%+3/?6/%/:EK:@+1D/!/#

    Load List) %#R*!#%/Z+63/1%D,IE):!. I3:E!#)+36B:*%:

    =:@3?/!G@/%+B.

    2 TDE/!+3/>V, A3:ED!#6=/A#3#356=+6:*.

    NE%,$b"6)b"%"',0:"9,%,%?H:20)$8,D'J7$2L,!2X')/$2/QC (Calib/QC Load List)2777,$!,

    :)6"0%2!2""/$)''"$%+JP:)72=2P.

    c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2,06.8,6"+,F",D"+%+EY$,00"%+,0%'. A-10.

    e >4B=:4'A/%+B@:=:4%+3/45%:, +%F:!1#&++, 61.

    : Z=+6:*e#

  • 7/23/2019 3193 Instruction RU e411

    140/379

    Roche DiagnosticsB-24 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q)2.:+"D+-1-'D':'1':"

    2 e#1/%+3/3!/E'/1D/!/#

    53). B-15 f"D:742"-'

  • 7/23/2019 3193 Instruction RU e411

    141/379

    Roche DiagnosticsB-25 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q)

    ProCell/CleanCell.

    e >4B=:4'A/%+B@:=:4%+3/45%:, +%F:!1#&++=:R3+16+

  • 7/23/2019 3193 Instruction RU e411

    142/379

    Roche DiagnosticsB-26 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q)

    :*%:2%?/%3#!%:

  • 7/23/2019 3193 Instruction RU e411

    143/379

    Roche DiagnosticsB-27 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q)

    ^2+,!27,=22%#63!. C-30.

    5 e#=:4%+3/*:%3/,%/!@+63+44+!:?#%%:,+4+@/+:%+)+!:?#%%:,?:@:,.

    6 -/:EK:@+1:@:E#?+35SysWash ?=!:=:!&++100+1. >:E#?53/35 14SysWash *

    @+63+44+!:?#%%:,+4+@/+:%+)+!:?#%%:,?:@/, )#4+?#B#**'!#3%:, ?:

    +)E/G#%+/!#6=4/6*+?#%+B.

    7 TD6'N+3/?%/N%MM=:?/!K%:635*:%3/,%/!#6=:1:H5ME'1#G%DK

    =:4:3/%/&, )#*!:,3/*:%3/,%/!*!DN*:,+=:1/63+3//

  • 7/23/2019 3193 Instruction RU e411

    144/379

    Roche DiagnosticsB-28 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q)

    ?:@:,.

    6 8!:3!+3/?%/N%MM=:?/!K%:635*:%3/,%/!#E'1#G%D1=:4:3/%&/1.

    7 Z=:1:H5ME'1#G%:

  • 7/23/2019 3193 Instruction RU e411

    145/379

    Roche DiagnosticsB-29 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q)

    c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06\X',X)%$,)%Y)

  • 7/23/2019 3193 Instruction RU e411

    146/379

    Roche DiagnosticsB-30 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    Q)

  • 7/23/2019 3193 Instruction RU e411

    147/379

    Roche DiagnosticsB-31 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    148/379

    Roche DiagnosticsB-32 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

    c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06. +"-Roche $)+%')!2+,0%'. A-15.

    O/L"4$/$/23G/+%%'3$%1+%2-;1/J+/+3'C

    1 8:@

    +%63!'1/%3#. Z4/@',3/?#N+14:*#45%D1=!#?+4#1=:?D=:4%/%+M

    @:=:4%+3/45%DK*:%3!:4/,?4#E:!#3:!++.

    3 e#

  • 7/23/2019 3193 Instruction RU e411

    149/379

    Roche DiagnosticsB-33 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++:

    L,$+,7+,9,%?:)72=22$,!2X',%)')/2$)+%')!"T%#63!. B-104

    c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06. +"-Roche$)+%')!2+,0%'. A-15.

    c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06. FJ9+)"+,7+,9"+2"$)+%"T+"')/)X',7=)/+,0%'. A-9..

    @$/13%'/13-J+3Y-$%($/+%Q-$$/23G/+%%'3$%1+%2-;

    Z*#%+!:?#%+/N3!+K-*:@*#!3:A/*64/@'/3?D=:4%B35, =!+)#

    :E!#H/%%D1*)#@%/,A#63+#%#4+)#3:!#. T63#?53/*#!3:A*' ?63#%&+M1#*6+1#45%:

    j63#%:?*#(QC > Install) .

    2 T63#?53/N3!+K-*:@*#!3:A*'?63#%&+M6A+3D?#%+B*#!3:A/*, 6N3!+K-

    *:@:1, :E!#H/%%D1 * )#@%/, A#63+ #%#4+)#3:!#. T63#?53/ *#!3:A*' ?

    63#%&+M1#*6+1#45%:

  • 7/23/2019 3193 Instruction RU e411

    150/379

    Roche DiagnosticsB-34 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    151/379

    Roche DiagnosticsB-35 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+1"1.

  • 7/23/2019 3193 Instruction RU e411

    152/379

    Roche DiagnosticsB-36 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

    1 TDE/!+3/QC > Install.

    R$+3'/?38QC +-)+/

    53). B-23 W2:"-QC > ])+/1%'$/(QC > Install)

    2 TDE/!+3/3!/E'/1D,*:%3!:45+)6=+6*#*:%3!:4/,

    3 TDE/!+3/3/63, *:3:!D/?DK:3+3/#*3+?+!:?#35 +)6=+6*#*:%3!:4/,.

    4 TDE/!+3/V*3+?%D,_/63(Active Test) @4B#*3+?#&++?DE!#%%:4B@/#*3+?#&++#*3+?%:

  • 7/23/2019 3193 Instruction RU e411

    153/379

    Roche DiagnosticsB-37 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+94:--13-$/23G/+%%'3$%1+%2-;

    1 -#G1+3/Z3#!3(Start) (

    ?D=:4%/%+/*#4+E!:?*++*:%3!:4B.

    d0!2XE!,/EX',+,,/%)6,%29"0$,.',0:"9,%$,/S%2!2%,(Utility) > H20%"6,(Utility >

    System)(H%'. 2/3) > S0%,+)/$2c)$J6"+%2')/,+2.(Documentation Setup) , :'27,/"'_"+22

    $,!2X')/$2,/%)6,%29"0$2XJ

  • 7/23/2019 3193 Instruction RU e411

    154/379

    Roche DiagnosticsB-38 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    155/379

    Roche DiagnosticsB-39 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+ Z3#3'6(Calibration > Status) . 26=:45)',3/R3:3R*!#%

    @4B?DE:!#3/63:?=:)#1/%/, 3#,1#'3'+4+%#!'N/%+MQC.

    53). B-26 W2:"-]1"17$Q").3:'

  • 7/23/2019 3193 Instruction RU e411

    156/379

    Roche DiagnosticsB-40 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    157/379

    Roche DiagnosticsB-41 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    Individual) .a3:ED:E/6=/A+35K:!:N//*#A/63?:63#3+63+A/6*+K@#%%DK,

    ?#G%:!/

  • 7/23/2019 3193 Instruction RU e411

    158/379

  • 7/23/2019 3193 Instruction RU e411

    159/379

    Roche DiagnosticsB-43 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    160/379

    Roche DiagnosticsB-44 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    161/379

    Roche DiagnosticsB-45 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+-;)%:

    -#R*!#%/Z+63/1#(j3+4+3#> Z+63/1#(Utility > System)), )%#A/%+/@4B

    j63#%:?*#d3!+K-*:@:?stat/Z3#%@#!3%D/ (Barcode Setting Stat/Routine) @:4G%:

    ED35>V.

    TC,%21-13-,%L/::3%'/138,%%G/4?/:

    TD=:4%/%+/=!:

    )0%,+,/!2/,"%0./:)72=2230.

  • 7/23/2019 3193 Instruction RU e411

    162/379

  • 7/23/2019 3193 Instruction RU e411

    163/379

    Roche DiagnosticsB-47 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    '=!#?4BMH/,6+63/1D. -:1/!=:64/@:?#3/45%:63+ =!+6?#+?#/36B**#G@:1' ID ?:

    ?!/1B)#

    (Work List) ,!#6=/A#3#%%D,?*:%&/=!:

    c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06. 8,D'J7$,2',7D'J7$,

  • 7/23/2019 3193 Instruction RU e411

    164/379

    Roche DiagnosticsB-48 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+6@/4#%D.

    1 TDE/!+3/Z3#!3(Start) (

  • 7/23/2019 3193 Instruction RU e411

    165/379

    Roche DiagnosticsB-49 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    166/379

    Roche DiagnosticsB-50 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    167/379

    Roche DiagnosticsB-51 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    168/379

    Roche DiagnosticsB-52 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    169/379

    Roche DiagnosticsB-53 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    170/379

    Roche DiagnosticsB-54 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+1"1.

    IEB)#3/45%:'*#G+3/ID N3#3+?#+%:1/!=:)+&++%#'=!#?4BMH/,

    6+63/1/.

    2 P#6=/A#3#,3/!#E:A+,6=+6:*%#'=!#?4BMH/,6+63/1/.

  • 7/23/2019 3193 Instruction RU e411

    171/379

    Roche DiagnosticsB-55 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    1 -#G1+3/Z3#!3(Start) (

  • 7/23/2019 3193 Instruction RU e411

    172/379

    Roche DiagnosticsB-56 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

    %'G%: TDE:!_/63:?(Test Selection) .

    53). B-45 W2:"-R?3':O+$1'1"1.*4#?+#3'!D. T?/@+3/ID :E!#)(Sample ID) ?6::3?/363?'MH//=:4/.

    4 TDE/!+3/8!/@?#!+3/45%:/P#)E#?4/%+/T*4. (Pre-dilution On) X64+:E!#)/&'G/ED4!#)E#?4/%?!'A%'M.

    5 -#G1+3/*%:=*'-:!1#45%#B+4+j1/%5N/%%#B(Normal or Reduced) @4B8!:E+!*#IE!#)(Sample Cup) .

    6 TDE/!+3/3!/E'/1:/!#)E#?4/%+/@4B:E!#), /64+%'G%:, ?=:4/6=+6*#

    IEi/1IE!#)/P#)E#?4/%+/(Sample Volume/Dilution) .

    7 TDE/!+3/3/63, *:1E+%#&+M3/63:?+4+=!:F+4+3/63:?@4B:E!#)?

    1#3!+&/3/63:?DK*4#?+N. TDE!#%%D/*4#?+N+3/63:?+=!:F+4/,

    :3:E!#G#M36BE/4D1&?/3:1.

    8 TDE/!+3/Z:K!#%+35(Save) @4B6:K!#%/%+B?DE:!*+3/63:?.

  • 7/23/2019 3193 Instruction RU e411

    173/379

    Roche DiagnosticsB-57 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    %#63!:,*+:34+A#M36B:33!/E'/1DK, ?%/6+3/%/:EK:@+1D/+)1/%/%+B.

    3 TDE/!+3/Z3#!3(%#R*!#%/j64:?+Be#='6*#(Start Conditions) ). Z+63/1#

    ?D=:4%+3=!:&/66+6K:@%:,=:@

  • 7/23/2019 3193 Instruction RU e411

    174/379

    Roche DiagnosticsB-58 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    1 TDE/!+3/P#E:A//]/63:(Workplace) > TDE:!_/63:?(Test Selection) .

    53). B-47 W2:"-R?3':O+$1'1"1.

    ?!/1B, =!:?/!53/, A3:+1//36B=:@@:%%#4+%++C (?DK:@%:,E'F/!). X64+

    %/:EK:@+1:, =:1/63+3/=:@@:%%#4+%+MC.

  • 7/23/2019 3193 Instruction RU e411

    175/379

  • 7/23/2019 3193 Instruction RU e411

    176/379

    Roche DiagnosticsB-60 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

    ?6/

  • 7/23/2019 3193 Instruction RU e411

    177/379

    Roche DiagnosticsB-61 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    178/379

  • 7/23/2019 3193 Instruction RU e411

    179/379

  • 7/23/2019 3193 Instruction RU e411

    180/379

    Roche DiagnosticsB-64 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

    1 TDE/!+3/P#E:A//]/63:(Workplace) > TDE:!_/63:?(Test Selection) .

    53). B-52 R?3':O+$1'

    5 TDE/!+3/8!/@?#!+3/45%:/P#)E#?4/%+/T*4. (Pre-dilution On) X64+:E!#)/&'G/ED4!#)E#?4/%?!'A%'M.

    6 -#G1+3/*%:=*'-:!1#45%#B+4+j1/%5N/%%#B(Normal or Reduced) @4B8!:E+!*#IE!#)(Sample Cup) .

    c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2,06>0:)!?7)/,+2"62$'):')X2')$+,0%'. A-17.

    7 TDE/!+3/3!/E'/1:/!#)E#?4/%+/@4B:E!#), /64+%'G%:, ?=:4/6=+6*#IEi/1

    IE!#)/P#)E#?4/%+/(Sample Volume/Dilution) .

  • 7/23/2019 3193 Instruction RU e411

    181/379

    Roche DiagnosticsB-65 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    =:)+&+,.

    K%L/::3%'/13-STAT %G/4?%')J+3Y-$%(/:3

    1 e#

    2 TDE/!+3/S.Stop (I63#%:?*#=/!/%:6#:E!#)&:?), +?D=:4%+3/

    Z*#%+!:?#%+/IE!#)&:?.

  • 7/23/2019 3193 Instruction RU e411

    182/379

  • 7/23/2019 3193 Instruction RU e411

    183/379

    Roche DiagnosticsB-67 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    %#63!:,*+%/3#*+/, *#*3!/E'/36B, %'G%:=!:+)?/63+%/:EK:@+1D/+)1/%/%+B..

    3 TDE/!+3/Z3#!3(%#R*!#%/j64:?+Be#='6*#(Start Conditions) ). Z+63/1#

    ?D=:4%+3=!:&/66+6K:@%:,=:@

  • 7/23/2019 3193 Instruction RU e411

    184/379

    Roche DiagnosticsB-68 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38

    H%,+-;)%:

    K%L/::3%'/13- STAT %G/4?%'

    1 TD=:4%+3/=!:1:.@-2'6"5.

  • 7/23/2019 3193 Instruction RU e411

    185/379

    Roche DiagnosticsB-69 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

  • 7/23/2019 3193 Instruction RU e411

    186/379

    Roche DiagnosticsB-70 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+1"1.

    7 TDE/!+3/8!/@?#!+3/45%:/P#)E#?4/%+/T*4. (Pre-dilution On) X64+:E!#)/&'G/ED4!#)E#?4/%?!'A%'M.

    8 -#G1+3/*%:=*'-:!1#45%#B+4+j1/%5N/%%#B(Normal or Reduced) @4B8!:E+!*#IE!#)(Sample Cup) .

    c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06>0:)!?7)/,+2"62$'):')X2')$+,0%'. A-17.

    9 TDE/!+3/3!/E'/1:/!#)E#?4/%+/@4B:E!#), /64+%'G%:, ?=:4/6=+6*#IEi/1IE!#)/P#)E#?4/%+/

    (Sample Volume/Dilution) .

    10 TDE/!+3/3/63, *:1E+%#&+M3/63:?+4+=!:F+4+3/63:?@4B:E!#)?1#3!+&/3/63:?DK*4#?+N. TDE!#%%D/

    *4#?+N+3/63:?+=!:F+4/,:3:E!#G#M36BE/4D1&?/3:1.

    11 TDE/!+3/Z:K!#%+35(Save) @4B6:K!#%/%+B?DE:!*+3/63:?.

  • 7/23/2019 3193 Instruction RU e411

    187/379

    Roche DiagnosticsB-71 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    53). B-59 f"D:742"'3:"4I'1:.@-2'6"5.

  • 7/23/2019 3193 Instruction RU e411

    188/379

    Roche DiagnosticsB-72 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

    !#E:A+16=+6*:1'=!#?4BMH/,6+63/1D.

    2 e#

  • 7/23/2019 3193 Instruction RU e411

    189/379

    Roche DiagnosticsB-73 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    1 TDE/!+3/Z3#!3(Start) (

  • 7/23/2019 3193 Instruction RU e411

    190/379

    Roche DiagnosticsB-74 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+3/63:?.

    d0!2%'"XJ"%0.+"0$)!?$) STAT_%,%2/)/, /E TDE:! _/63:?(Test

    Selection) +?D=:4%BM36B#%#4+)#3:!:1#?3:1#3+A/6*+.

    53). B-63 W2:"-R?3':O+$1'

  • 7/23/2019 3193 Instruction RU e411

    191/379

    Roche DiagnosticsB-75 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    5"Q1%-,-('/3+-271%-/4G/'2-13-%G/4?%'

    X64+:E!#)/&!#)E#?4B/36B?!'A%'M=/!/@#%#4+):1, ?D1:G/3/%#63:+35+%63!'1/%3

    @4B#%%DK(Data Review) .

    9(-1+3>3$/?38%G/4?/$/$,-('/3+-271%/4G/'2-11%L%

    1 TDE/!+3/P#E:A//]/63:(Workplace) > TDE:!_/63:?(Test Selection) @4B

    :3:E!#G/%+B:@%:+1/%%:

    >76"'"+2.0%,+

  • 7/23/2019 3193 Instruction RU e411

    192/379

    Roche DiagnosticsB-76 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+

    ?/!K%/,4/?:,A#63+R*!#%#) @4B:3:E!#G/%+B:*%#IE):!Z+63/1D(System

    Overview) .

    2 TDE/!+3/I364/G+?#%+/IE!#)&:?(Sample Tracking) @4B:3:E!#G/%+B:@%:+1/%%:

  • 7/23/2019 3193 Instruction RU e411

    193/379

    Roche DiagnosticsB-77 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    D+)2-B3'/13-DG/4?%'(Sample Tracking) ')3)+-:-

    1 TDE/!+3/

  • 7/23/2019 3193 Instruction RU e411

    194/379

  • 7/23/2019 3193 Instruction RU e411

    195/379

    Roche DiagnosticsB-79 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    H%,+

    6:E4M@#B=!+R3:1%/:EK:@+1D/1/!D=!/@:63:!:G%:63+.

    A

    C

    V'66'-3

    V'66'-1

    B V'66'-2

    53). B-68 G3)"$1.&'66'-'

    #%#4+)#3:!%#A+%#/3+6=:45):?#35=:@@:%1.

  • 7/23/2019 3193 Instruction RU e411

    196/379

    Roche DiagnosticsB-80 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    H%,+:3:E!#G#/36B%#R*!#%/Z+63/1%D,IE):!(System Overview) . -#P+6. B-69,

    =:*#)#%#2%?/%3#!%#B:E4#635, 6'*#)#%+/11#!*/!:?=:)+&++)#K?#3A+*#+

    =:)+&+M=:@@:%#1 @4B!/#*&+:%%DKBA//*+%#*:%/A%+*:?. 8:@@:%D2 +3

    )#=:4%/%D+@4B3:

    %#*:%/A%+*:?1:

  • 7/23/2019 3193 Instruction RU e411

    197/379

    Roche DiagnosticsB-81 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    F"7J!?%,%E

    @3:'%2C@3)+-:1%L%

    DG4%/(System Overview)

    (,%G3$3/1/$%1-Q13$3)

    D,?334/L"4$3

    -/)#

    ]:G/3/)#

    ]:G/3/ )#

    ]:G/3/)#

    [/G23?/B -3

    V:.5+:?'&I.B4"D:742.

  • 7/23/2019 3193 Instruction RU e411

    198/379

  • 7/23/2019 3193 Instruction RU e411

    199/379

    Roche DiagnosticsB-83 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    F"7J!?%,%E

    53). B-71 W2:"-G34':c"--?@(Data Review) (>1"1.#%%DK(Data

    Review) ?%+):33/*'H/

  • 7/23/2019 3193 Instruction RU e411

    200/379

    Roche DiagnosticsB-84 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    F"7J!?%,%E

    6 -#G1+3/I31/%#@4B)#*!D3+B:*%#8:+6*IE!#)&:?+?:)?!#H/%+B%#

    R*!#%IE):!>#%%DK(Data Review) . TDE!#%%D,:E!#)/&?D@/4B/36B.

    b327+/?38-4"27+/+%',%,/?3-1+/:

    26=:45)',3/R3'F'%*&+M@4BF+453!#&++=:3+=':E!#)&:?, *:3:!D/?D

    K:3+3/=!:61:3!/35, @:*'1/%3+!:?#35+4+!#6=/A#3#35. -#63!:,*#F+453!#=:

    '1:4A#%+M TD*4.

    b327+/?38-4"27+/+%',%,/?3-1+/:

    1 -#G1+3/*%:=*'+453!@4B:3:E!#G/%+B:*%#+453!, +6=:45)'/1:#%%DK(Data Review) .

    3 TDE/!+3/T*4. ?:E4#63++453!%#R*!#%/IE):!>#%%DK(Data Review) @4B

    #*3+?#&++F+453!#. P/)'453#3DF+453!'M36B?6::3?/363?++6*!+3/!+/1

    F+453!#, *:3:!D,?D?DE!#4+.

    5/),-Q/+$/34/L"4$/-4"27+/+%',%,/?3-1+/:

    I*%:-#63!:,*+>:*'1/%3+!:?#%+B+8!+%3/!#=:)?:4BM3?#1?DE!#35

    %'G%'M:=&+M@:*'1/%3+!:?#%+B+R4/1/%3D@4B#?3:1#3+A/6*:, !#6=/A#3*+.

    d0!2/E/EX"'2%"8,D'J7$,, 2!2F,0:"9,%$,/8,D'J7$,,%):'2)%$!P9"++)T$)66J+2$,=220

    J:',/!.P["T020%"6)T+,W$',+"S0!)/2.8,:J0$,(Start Conditions) , D"+"'2'J"%0.02D+,!?+)"

    0))X["+2".

    5/),-Q/+$/3234/L"4$/-4"27+/+%',/?3-1+%'

    1 TDE/!+3/j3+4+3#(Utility) > Z+63/1#(Utility > System).

    2 TDE/!+3/63!. 2/3

    3 TDE/!+3/-#63!:,*#>:*'1/%3+!:?#%+B (Documentation Setup) @4B:3:E!#G/%+B

    :*%#-#63!:,*#>:*'1/%3+!:?#%+B+8!+%3/!#(Documentation and Printer Setup).

  • 7/23/2019 3193 Instruction RU e411

    201/379

    Roche DiagnosticsB-85 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    F"7J!?%,%E

    4 TDE/!+3/:=&+M?:E4#63+j64:?+Be#?/!N/%+B(Completion Conditions) .

    5 TDE/!+3/:=&+M?:E4#63+Z:/@+%/%+/68!+%3/!:1(Printer Connection) .

    6 TDE/!+3/:=&+M?:E4#63+V?3:1#3+A/6*#BP#6=/A#3*#(Automatic Printout) .

    7 -#G1+3/OK @4B6:K!#%/%+B?DE!#%%DK%#63!:/*+)#*!D3+B-#63!:,*#

    >:*'1/%3+!:?#%+B(Documentation Setup) .

    D,?33%G2/)+3])2%'38O/'-J-138(Completion Conditions)

    F,0:"9,%$,

    8,D'J7$,

    F,0:"9,%$,

    /8,D'J7$,

    8:64#35:3A/3D%#=!+%3/!.

    e#

    L,!2X')/$,\X',7=,

    L)+%')!?+ET

    \X',7"=

    STAT\X',7"=

    H%,+ IE):!

    >#%%DK(Data Review) .

    5/),-Q/+$/D+Q-+/,%5-4"27+/+/:

    1 TDE/!+3/3!/E'/1D/@#%%D/?P#E:A//]/63:(Workplace) > IE):!>#%%DK

    (Data Review) =/!/@!#6=/A#3*:,+=!:61:3!:1R3:

  • 7/23/2019 3193 Instruction RU e411

    202/379

    Roche DiagnosticsB-86 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    F"7J!?%,%E

    53). B-74 /2:"-V+E"19"3'E+D'K+$1"(Workplace Print)

    4 TDE/!+3/I3A/3=:P/)'453#3#1(Result Report) +)6=+6*#b4/1/%3DP#E:A/

  • 7/23/2019 3193 Instruction RU e411

    203/379

    Roche DiagnosticsB-87 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    Q)0%-):"',=2)++)"J:',/!"+2"j@#4B,3/@:*'1/%3+!:?#%%D/ :E!#)&D@4B?D6?:E:G@/%+B@:=:4%+3/45%:DE59-$(System Overview) (h+@P#E:A/ IA+63*#>#%%DK=::E!#)(Sample Data Clear) .

    2 TDE/!+3/j@#4+35T6/(Delete All) @4B'@#4/%+B@#%%DK=::E!#).

    jB-(1-'1%-%G)2"B3'/13-

    8/!/@)#?/!N/%+/163#%@#!3%:,!#E:3D, ?#G%:'@:63:?/!+36B, A3:?D=:4%/%D?6/

    %/:EK:@+1D/@/,63?+B:E64'G+?#%+B. >:=:4%+3/45%:*63#%@#!3%:1'@%/?%:1'

    :E64'G+?#%+M, 3#*G/64/@'/3?D=:4%B35@!'

  • 7/23/2019 3193 Instruction RU e411

    204/379

    Roche DiagnosticsB-88 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    NE$!P9"+2",+,!27,%)',

    TC$2PQ-13-/1/234/+%/

    8:64/)#?/!N/%+B63#%@#!3%:,!#E:3D+?D=:4%/%+B?6/H20%"6,(Utility > System).

    TC$2PQ-13-/1/234/+%/

    1 j63#%:?+3/:=/!#&+:%%D,=/!/*4MA#3/45?=:4:G/%+/TD*4. I3:E!#)+36B:*%:Z:%(Sleep) (C/)@/,63?+/).

    53). B-75 G2-']'-(Sleep)

    N )$+"H)+(Sleep) +"/EX2',T%"NE$!P9"+2", "0!2/E+"Y)%2%")%$!P9,%?/0"^J+$=22

    2$)6:)+"+%E,+,!27,%)',.

    Q'2/EX)'"NE$!P9"+2"Q2%,+2.:))_2X$", /E$!P92%"D!,/+ET%J6X!"':2%,+2.,

    :)

  • 7/23/2019 3193 Instruction RU e411

    205/379

    Roche DiagnosticsB-89 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38

    NE$!P9"+2",+,!27,%)',

    1 I3*!:,3/6+==/!%D,H+3:*, %#@#?+?%#E/4'M1/3#44+A/6*'M:E4#635

    %#?/!K', *#*=:*#)#%:%#64/@'MH/1!+6'%*/, @:?D6?:E:G@/%+B)#H/4*+.

    A

    A _"*5.1+46+$96)='12:?1.=.).4"2:?1.=$.&&+:-'D'T.12"

    53). B-76 G12:'B1+$.&&+:-?BT.1'2

    2 e#*!:,3/*!DN*+%#E'3D4*#KProCell +CleanCell.

    53). B-77 f"2:'B1+2:?>2.ProCell/CleanCell

  • 7/23/2019 3193 Instruction RU e411

    206/379

    Roche DiagnosticsB-90 5"$%'%()+'%%,-/+%/ T-)381.0

    6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411

    NE$!P9"+2",+,!27,%)',

    3 e#*!:,3/H+3:*6+==/!#, %#@#?+?%#E/4'M1/K#%+A/6*'M:E4#635%#?/!K',

    =:*#?D%/'64DN+3/H/4A:*, '*#)D?#MH+,%#)#*!D3+/)#H/4*+.

    K%'-$3,3,%21%:'C$2PQ-133,3+/138

    X64+ #%#4+)#3:! E'@/3 ?D*4MA/% @:45N/ 6/1+ @%/,, ?#G%:

    6::3?/363?'MH+1 :E!#):1 =:@

  • 7/23/2019 3193 Instruction RU e411

    207/379

    Roche DiagnosticsB-91 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 7 @,-?3/271C-%,-/?33: =/$?...

    @,-?3/271C-%,-/?33: =/$?...

    TR3:,

    \#*%#)%#A#35=:)+&++*#4+E!#3:!:?+*:%3!:4/,........................................... 104

    \#*'63#%#?4+?#35+:=!/@/4B35*:%3!:4+Roche...................................... ...... 106

    \#*'63#%#?4+?#35+:=!/@/4B35%/Roche *:%3!:4+ ...................................... 107

    \#*!/@#*3+!:?#35*:%3!:45%D/)%#A/%+B ........................................................ 109

    \#*)#=!#N+?#35 QC @4BE'3D4*+?!/G+1/:G+@#%+B................................... 110

    \#*:31/%B35)#@#%+/=/A#3+ ...................... ............................................. ...... 111

    \#*!#6=/A#3D?#35/G/@%/?%D,:3A/3I364/G+?#%+/Z+\#*+)1/%B35%#63!:,*+3/63:? .......................................................................... 116

    \#*+)1/%B35%#63!:,*+*#4+E!:?*+ .................................................................. 118

    \#*+)1/%+35!/G+1@+6*#:E!#)&:? ................................................................. 119

  • 7/23/2019 3193 Instruction RU e411

    208/379

    Roche DiagnosticsB-92 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 7 @,-?3/271C-%,-/?33: =/$?...

  • 7/23/2019 3193 Instruction RU e411

    209/379

    Roche DiagnosticsB-93 5"$%'%()+'%%,-/+%/ T-)381.0

    /1/234/+%cobas e 411 7 @,-?3/271C-%,-/?33: =/$?...

    \X7)'

    DG4%

    Z/*&++?R3:,/3#4+=:!#)4+A+M1/G@'@+6*:?:,+N3#3+?%:,6+63/1:,, 61. ?c20$)/,.2

    _%,%2/+,.020%"6E+,0%'.B-5.

  • 7/23/2019 3193 Instruction RU e411

    210/379

    Roche DiagnosticsB-94 5"$%'%()+'%%,-/+%/ T-)381.0

    7 @,-?3/271C-%,-/?33: =/$?... /1/234/+%cobas e 411

    L,$20:)!?7)/,%?W%2$"%$2_%'2Y-$)=/$3),%274%'/+7V+3$-+$3J+3Y-$%(%'(28,%G3%$3-:$%)+-;

    P#)1/!+!#)1/H/%+/N3!+K-*:@R3+*/3:*%#*:%3/,%/!#K@4B:E!#)&:?,

    *#4+E!#3:!:?+*:%3!:4/,, @:4G%::3?/A#35:=!/@/4/%%D1 6=/&+F+*#&+B1.

    Z*#%/!N3!+K-*:@:?1:G/3%/A+3#35R3+*/3*+=!+%/6:E4M@/%++@#%%DK

    '64:?+,.

    9),%274%'/13-J+3Y-$%(V+3$-+%$1/,%G3$/Y%G/4?%', 3-:$%)+8Y

    (28$/23G/+%%'3$%1+%2-;

    1 jE/@+3/65, A3:!#)1/!DN3!+K-*:@R3+*/3:*3#*+/, *#*'*#)#%D%#!+6. B-78.

    A M.:.-"/1.2+12"(16 55

    5.-.575) C _+B1:")9-"=4'-"

    (5555.-.575)

    E _+B1:")9-"=4'-"(5555.-.575)

    B M.:.-">1:.@-2'6"(1255

    5.-.575) D f'-">1:.@-2'6"(50 55

    5"2$.5756)=10055&:'3.:'2; 38

    555"2$.5756)=7555&:'3.:'2)

    O(&. B-78 P#)1/!DN3!+K-*:@R3+*/3:*@4B=!:E+!:*+/1*:63/,

    2 >4B=!:E+!:*:E!#)&:?, =:1/63+3/N3!+K-*:@R3+*/3*+?6::3?/363?++?

    6::3?/363?++6: